| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | integrin binding | FBLN1 FN1 LAMA5 LAMB1 ESM1 CCN2 ADAMTS8 ADAM11 TNR ITGB1 ITGB3 TNXB ITGB6 ITGB7 | 8.50e-15 | 175 | 80 | 14 | GO:0005178 |
| GeneOntologyMolecularFunction | calcium ion binding | SNED1 USP6 FBLN1 NELL2 CELSR1 MEGF6 MEGF8 SLIT1 LRP1 LRP4 DLL1 ITGB1 LRP1B CDH11 FBN3 EGFEM1P CRB2 OC90 | 7.07e-10 | 749 | 80 | 18 | GO:0005509 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FBLN1 FN1 NRXN2 LAMA5 LAMB1 ESM1 CCN2 ADAMTS8 ADAM11 TNR ITGB1 ITGB3 TNXB ITGB6 ITGB7 CDH11 | 1.60e-09 | 599 | 80 | 16 | GO:0050839 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.01e-09 | 188 | 80 | 10 | GO:0005201 | |
| GeneOntologyMolecularFunction | heparin binding | 1.01e-06 | 192 | 80 | 8 | GO:0008201 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 5.74e-06 | 323 | 80 | 9 | GO:1901681 | |
| GeneOntologyMolecularFunction | coreceptor activity | 1.03e-05 | 72 | 80 | 5 | GO:0015026 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.10e-05 | 73 | 80 | 5 | GO:0050840 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.19e-05 | 268 | 80 | 8 | GO:0005539 | |
| GeneOntologyMolecularFunction | fibronectin binding | 1.59e-05 | 38 | 80 | 4 | GO:0001968 | |
| GeneOntologyMolecularFunction | virus receptor activity | 2.32e-05 | 85 | 80 | 5 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 2.46e-05 | 86 | 80 | 5 | GO:0140272 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor receptor binding | 4.04e-05 | 17 | 80 | 3 | GO:0005161 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.21e-04 | 120 | 80 | 5 | GO:0004222 | |
| GeneOntologyMolecularFunction | C-X3-C chemokine binding | 1.57e-04 | 5 | 80 | 2 | GO:0019960 | |
| GeneOntologyMolecularFunction | fibrinogen binding | 2.35e-04 | 6 | 80 | 2 | GO:0070051 | |
| GeneOntologyMolecularFunction | collagen binding | 3.14e-04 | 81 | 80 | 4 | GO:0005518 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 3.35e-04 | 547 | 80 | 9 | GO:0048018 | |
| GeneOntologyMolecularFunction | sphingolipid binding | 3.39e-04 | 34 | 80 | 3 | GO:0046625 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 3.68e-04 | 554 | 80 | 9 | GO:0030546 | |
| GeneOntologyMolecularFunction | frizzled binding | 6.35e-04 | 42 | 80 | 3 | GO:0005109 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 7.88e-04 | 616 | 80 | 9 | GO:0030545 | |
| GeneOntologyMolecularFunction | protease binding | 8.04e-04 | 181 | 80 | 5 | GO:0002020 | |
| GeneOntologyMolecularFunction | structural molecule activity | 8.23e-04 | 891 | 80 | 11 | GO:0005198 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.12e-03 | 51 | 80 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | glycosphingolipid binding | 1.20e-03 | 13 | 80 | 2 | GO:0043208 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.25e-03 | 200 | 80 | 5 | GO:0008237 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.68e-03 | 430 | 80 | 7 | GO:0004175 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.83e-03 | 16 | 80 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 2.59e-03 | 19 | 80 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 2.87e-03 | 20 | 80 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 3.17e-03 | 21 | 80 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | molecular function activator activity | ARHGAP5 FBLN1 FN1 SEMA5B WNT3 PDGFD WNT10A CCN2 LTF WNT4 DLL1 PDGFC | 3.56e-03 | 1233 | 80 | 12 | GO:0140677 |
| GeneOntologyMolecularFunction | peptidase regulator activity | 3.73e-03 | 257 | 80 | 5 | GO:0061134 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 4.83e-03 | 85 | 80 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 5.16e-03 | 173 | 80 | 4 | GO:0070851 | |
| GeneOntologyMolecularFunction | Notch binding | 5.21e-03 | 27 | 80 | 2 | GO:0005112 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 5.21e-03 | 27 | 80 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 6.00e-03 | 29 | 80 | 2 | GO:0043395 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | ADAMTS19 FBLN1 MELTF FN1 ADAMTSL5 ADAMTS7 LAMA1 LRP1 LAMB1 MANSC4 CCN2 ADAMTS8 TNR ITGB1 ITGB3 TNXB | 1.29e-12 | 377 | 81 | 16 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | ADAMTS19 FBLN1 MELTF FN1 ADAMTSL5 ADAMTS7 LAMA1 LRP1 LAMB1 MANSC4 CCN2 ADAMTS8 TNR ITGB1 ITGB3 TNXB | 1.34e-12 | 378 | 81 | 16 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | ADAMTS19 FBLN1 MELTF FN1 ADAMTSL5 ADAMTS7 LAMA1 LRP1 LAMB1 MANSC4 CCN2 ADAMTS8 TNR ITGB1 ITGB3 TNXB | 1.40e-12 | 379 | 81 | 16 | GO:0045229 |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | FBLN1 FN1 LAMA1 LAMA5 LAMB1 CCN2 ADAM11 ITGB1 ITGB3 ITGB6 ITGB7 | 2.01e-12 | 124 | 81 | 11 | GO:0007229 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | SNED1 FBLN1 MELTF FN1 LRP1 LAMA5 LAMB1 CCN2 LIMCH1 WNT4 ITGB1 ITGB3 TNXB ITGB6 ITGB7 CDH11 | 4.59e-12 | 410 | 81 | 16 | GO:0031589 |
| GeneOntologyBiologicalProcess | axon guidance | ABLIM1 NELL2 MEGF8 SEMA5B WNT3 NTN3 SLIT1 LAMA1 LRP1 NGFR LAMA3 LAMA5 LAMB1 TNR | 5.35e-12 | 285 | 81 | 14 | GO:0007411 |
| GeneOntologyBiologicalProcess | axonogenesis | ABLIM1 NELL2 FN1 MEGF8 SEMA5B WNT3 NTN3 SLIT1 LAMA1 LRP1 NGFR LAMA3 LRP4 LAMA5 LAMB1 TNR ITGB1 CDH11 | 5.47e-12 | 566 | 81 | 18 | GO:0007409 |
| GeneOntologyBiologicalProcess | neuron projection guidance | ABLIM1 NELL2 MEGF8 SEMA5B WNT3 NTN3 SLIT1 LAMA1 LRP1 NGFR LAMA3 LAMA5 LAMB1 TNR | 5.61e-12 | 286 | 81 | 14 | GO:0097485 |
| GeneOntologyBiologicalProcess | regulation of locomotion | ARHGAP5 FBLN1 PHPT1 FN1 MEGF8 SEMA5B WNT3 PDGFD SLIT1 LAMA1 LRP1 NGFR LAMA3 LAMA4 LAMA5 LAMB1 LIMCH1 WNT4 PDGFC MUC2 TNR ITGB1 ITGB3 TNXB CDH11 | 2.08e-11 | 1327 | 81 | 25 | GO:0040012 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ABLIM1 NELL2 FN1 MEGF8 SEMA5B WNT3 NTN3 SLIT1 LAMA1 LRP1 NGFR LAMA3 LRP4 LAMA5 LAMB1 PRKN TNR ITGB1 ITGB3 CDH11 | 4.19e-11 | 826 | 81 | 20 | GO:0048858 |
| GeneOntologyBiologicalProcess | axon development | ABLIM1 NELL2 FN1 MEGF8 SEMA5B WNT3 NTN3 SLIT1 LAMA1 LRP1 NGFR LAMA3 LRP4 LAMA5 LAMB1 TNR ITGB1 CDH11 | 4.36e-11 | 642 | 81 | 18 | GO:0061564 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | ADAMTS19 ABLIM1 CELSR1 MEGF8 NSD2 WNT3 NTN3 SLIT1 LAMA1 NGFR LAMA3 LRP4 WNT10A LAMA5 LAMB1 CCN2 LTF WNT4 DLL1 PDGFC USH2A ITGB6 MEGF11 CRB2 | 5.42e-11 | 1269 | 81 | 24 | GO:0009887 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ABLIM1 NELL2 FN1 MEGF8 SEMA5B WNT3 NTN3 SLIT1 LAMA1 LRP1 NGFR LAMA3 LRP4 LAMA5 LAMB1 PRKN TNR ITGB1 CDH11 | 2.03e-10 | 802 | 81 | 19 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ABLIM1 NELL2 FN1 MEGF8 SEMA5B WNT3 NTN3 SLIT1 LAMA1 LRP1 NGFR LAMA3 LRP4 LAMA5 LAMB1 PRKN TNR ITGB1 CDH11 | 2.89e-10 | 819 | 81 | 19 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ABLIM1 NELL2 FN1 MEGF8 SEMA5B WNT3 NTN3 SLIT1 LAMA1 LRP1 NGFR LAMA3 LRP4 LAMA5 LAMB1 TNR ITGB1 CDH11 | 5.15e-10 | 748 | 81 | 18 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | SNED1 FN1 LRP1 CCN2 LIMCH1 WNT4 ITGB1 ITGB3 TNXB ITGB6 ITGB7 CDH11 | 6.29e-10 | 270 | 81 | 12 | GO:0007160 |
| GeneOntologyBiologicalProcess | regulation of cell motility | ARHGAP5 FBLN1 PHPT1 FN1 SEMA5B PDGFD LAMA1 LRP1 NGFR LAMA3 LAMA4 LAMA5 LAMB1 LIMCH1 WNT4 PDGFC MUC2 TNR ITGB1 ITGB3 TNXB CDH11 | 2.51e-09 | 1280 | 81 | 22 | GO:2000145 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ABLIM1 NELL2 FN1 MEGF8 SEMA5B WNT3 NTN3 SLIT1 LAMA1 LRP1 NGFR LAMA3 LRP4 LAMA5 LAMB1 PRKN TNR ITGB1 ITGB3 ITGB6 CDH11 | 4.21e-09 | 1194 | 81 | 21 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of cell migration | ARHGAP5 FBLN1 FN1 SEMA5B PDGFD LAMA1 LRP1 NGFR LAMA3 LAMA4 LAMA5 LAMB1 LIMCH1 WNT4 PDGFC MUC2 TNR ITGB1 ITGB3 TNXB CDH11 | 5.41e-09 | 1211 | 81 | 21 | GO:0030334 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | CELSR1 FN1 RNH1 MEGF8 WNT3 SLIT1 LRP1 NGFR LRP4 WNT10A PRKN WNT4 C6 DLL1 TNR ITGB1 ITGB3 MIEF2 CRB2 | 3.11e-08 | 1090 | 81 | 19 | GO:0022603 |
| GeneOntologyBiologicalProcess | axon extension | 5.88e-08 | 135 | 81 | 8 | GO:0048675 | |
| GeneOntologyBiologicalProcess | neuron projection development | ABLIM1 NELL2 FN1 MEGF8 SEMA5B WNT3 NTN3 SLIT1 LAMA1 LRP1 NGFR LAMA3 LRP4 LAMA5 LAMB1 PRKN TNR ITGB1 TNXB CDH11 | 8.13e-08 | 1285 | 81 | 20 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | FBLN1 MELTF FN1 LAMA1 LRP1 LAMA3 LAMA4 LAMA5 LAMB1 LIMCH1 WNT4 DLL1 TNR ITGB1 ITGB3 ZBTB1 TNXB | 9.18e-08 | 927 | 81 | 17 | GO:0030155 |
| GeneOntologyBiologicalProcess | neuron projection extension | 1.21e-07 | 207 | 81 | 9 | GO:1990138 | |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 1.23e-07 | 99 | 81 | 7 | GO:0045995 | |
| GeneOntologyBiologicalProcess | neuron development | ABLIM1 NELL2 FN1 MEGF8 SEMA5B WNT3 NTN3 SLIT1 LAMA1 LRP1 NGFR LAMA3 LRP4 LAMA5 LAMB1 PRKN TNR ITGB1 TNXB CDH11 CRB2 | 1.41e-07 | 1463 | 81 | 21 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 2.24e-07 | 108 | 81 | 7 | GO:0007044 | |
| GeneOntologyBiologicalProcess | substrate adhesion-dependent cell spreading | 2.39e-07 | 109 | 81 | 7 | GO:0034446 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 3.45e-07 | 115 | 81 | 7 | GO:0150115 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 9.68e-07 | 84 | 81 | 6 | GO:1903053 | |
| GeneOntologyBiologicalProcess | positive regulation of fibroblast proliferation | 1.04e-06 | 85 | 81 | 6 | GO:0048146 | |
| GeneOntologyBiologicalProcess | biological process involved in symbiotic interaction | 1.15e-06 | 351 | 81 | 10 | GO:0044403 | |
| GeneOntologyBiologicalProcess | odontogenesis | 2.17e-06 | 151 | 81 | 7 | GO:0042476 | |
| GeneOntologyBiologicalProcess | circulatory system development | ADAMTS19 FN1 RNH1 MEGF8 NSD2 PDGFD LAMA1 LRP1 NGFR LAMA4 ESM1 CCN2 WNT4 C6 DLL1 ITGB1 ITGB3 CDH11 CRB2 | 2.29e-06 | 1442 | 81 | 19 | GO:0072359 |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 2.62e-06 | 299 | 81 | 9 | GO:0060560 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 2.77e-06 | 301 | 81 | 9 | GO:0048588 | |
| GeneOntologyBiologicalProcess | blood vessel development | FN1 RNH1 MEGF8 PDGFD LAMA1 LRP1 NGFR LAMA4 ESM1 CCN2 WNT4 C6 DLL1 ITGB1 ITGB3 | 2.86e-06 | 929 | 81 | 15 | GO:0001568 |
| GeneOntologyBiologicalProcess | regulation of axon extension | 3.39e-06 | 104 | 81 | 6 | GO:0030516 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CELSR1 ZAN NRXN2 LAMA3 LAMB1 WNT4 TNR ITGB1 ITGB3 ZBTB1 TNXB ITGB6 ITGB7 MEGF11 CDH11 CRB2 | 3.72e-06 | 1077 | 81 | 16 | GO:0098609 |
| GeneOntologyBiologicalProcess | odontogenesis of dentin-containing tooth | 4.01e-06 | 107 | 81 | 6 | GO:0042475 | |
| GeneOntologyBiologicalProcess | vasculature development | FN1 RNH1 MEGF8 PDGFD LAMA1 LRP1 NGFR LAMA4 ESM1 CCN2 WNT4 C6 DLL1 ITGB1 ITGB3 | 4.78e-06 | 969 | 81 | 15 | GO:0001944 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | TRIM33 MEGF8 ADAMTS7 PDGFD LRP1 NGFR CCN2 WNT4 DLL1 ITGB1 ITGB3 TNXB ITGB6 CRB2 | 5.11e-06 | 850 | 81 | 14 | GO:0071363 |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 7.02e-06 | 254 | 81 | 8 | GO:0010810 | |
| GeneOntologyBiologicalProcess | response to growth factor | TRIM33 MEGF8 ADAMTS7 PDGFD LRP1 NGFR CCN2 WNT4 DLL1 ITGB1 ITGB3 TNXB ITGB6 CRB2 | 7.90e-06 | 883 | 81 | 14 | GO:0070848 |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 8.55e-06 | 122 | 81 | 6 | GO:0061387 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 1.06e-05 | 192 | 81 | 7 | GO:0050770 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | TRIM33 MEGF8 PDGFD LRP1 NGFR LRP4 ESM1 CCN2 WNT4 DLL1 PDGFC ITGB1 ITGB3 TNXB ITGB6 CRB2 | 1.25e-05 | 1186 | 81 | 16 | GO:0007167 |
| GeneOntologyBiologicalProcess | epidermis development | 1.28e-05 | 461 | 81 | 10 | GO:0008544 | |
| GeneOntologyBiologicalProcess | cell junction assembly | FN1 NRXN2 SLIT1 LRP1 LAMA3 LRP4 LIMCH1 WNT4 ITGB1 ITGB3 CDH11 | 1.35e-05 | 569 | 81 | 11 | GO:0034329 |
| GeneOntologyBiologicalProcess | regulation of fibroblast proliferation | 1.53e-05 | 135 | 81 | 6 | GO:0048145 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | FN1 RNH1 MEGF8 LAMA1 LRP1 NGFR ESM1 CCN2 WNT4 C6 DLL1 ITGB1 ITGB3 | 1.67e-05 | 817 | 81 | 13 | GO:0048514 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | MELTF NCAPG FN1 MEGF8 WNT3 LRP1 NGFR LRP4 SIVA1 PRKN CCN2 LIMCH1 WNT4 DLL1 ITGB1 TNXB MIEF2 | 1.83e-05 | 1366 | 81 | 17 | GO:0051130 |
| GeneOntologyBiologicalProcess | tube development | CELSR1 FN1 RNH1 MEGF8 LAMA1 LRP1 NGFR LAMA5 ESM1 CCN2 WNT4 C6 DLL1 PDGFC ITGB1 ITGB3 ITGB6 | 2.56e-05 | 1402 | 81 | 17 | GO:0035295 |
| GeneOntologyBiologicalProcess | tube morphogenesis | CELSR1 FN1 RNH1 MEGF8 LAMA1 LRP1 NGFR LAMA5 ESM1 CCN2 WNT4 C6 DLL1 ITGB1 ITGB3 | 2.80e-05 | 1125 | 81 | 15 | GO:0035239 |
| GeneOntologyBiologicalProcess | regulation of cell size | 2.94e-05 | 225 | 81 | 7 | GO:0008361 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | ARHGAP5 FBLN1 PHPT1 FN1 MEGF8 SEMA5B PDGFD LRP1 LAMB1 PDGFC ITGB1 ITGB3 | 3.12e-05 | 742 | 81 | 12 | GO:0040017 |
| GeneOntologyBiologicalProcess | biological process involved in interaction with host | 3.19e-05 | 228 | 81 | 7 | GO:0051701 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | FN1 MEGF8 WNT3 LAMA1 LRP1 NGFR LAMB1 CCN2 LTF WNT4 ITGB1 ITGB3 ZBTB1 TNXB CRB2 | 3.30e-05 | 1141 | 81 | 15 | GO:0045597 |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 3.40e-05 | 412 | 81 | 9 | GO:0090287 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | CELSR1 MEGF8 WNT3 LAMA1 NGFR WNT10A LAMA5 WNT4 DLL1 ITGB1 ITGB3 CRB2 | 3.46e-05 | 750 | 81 | 12 | GO:0048729 |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 3.67e-05 | 233 | 81 | 7 | GO:0031345 | |
| GeneOntologyBiologicalProcess | regulation of axon extension involved in axon guidance | 3.81e-05 | 17 | 81 | 3 | GO:0048841 | |
| GeneOntologyBiologicalProcess | fibroblast proliferation | 3.98e-05 | 160 | 81 | 6 | GO:0048144 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor diffusion trapping | 4.56e-05 | 3 | 81 | 2 | GO:0150054 | |
| GeneOntologyBiologicalProcess | regulation of substrate-dependent cell migration, cell attachment to substrate | 4.56e-05 | 3 | 81 | 2 | GO:1904235 | |
| GeneOntologyBiologicalProcess | positive regulation of substrate-dependent cell migration, cell attachment to substrate | 4.56e-05 | 3 | 81 | 2 | GO:1904237 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 4.89e-05 | 166 | 81 | 6 | GO:0098773 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | CELSR1 FN1 RNH1 WNT3 NTN3 NGFR ESM1 CCN2 WNT4 C6 DLL1 ITGB1 ITGB3 ITGB6 MEGF11 CDH11 CRB2 | 5.21e-05 | 1483 | 81 | 17 | GO:0048646 |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 5.41e-05 | 169 | 81 | 6 | GO:0010977 | |
| GeneOntologyBiologicalProcess | negative regulation of locomotion | 7.19e-05 | 454 | 81 | 9 | GO:0040013 | |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 8.51e-05 | 22 | 81 | 3 | GO:0048846 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 8.51e-05 | 22 | 81 | 3 | GO:1902284 | |
| GeneOntologyBiologicalProcess | calcium-independent cell-matrix adhesion | 9.09e-05 | 4 | 81 | 2 | GO:0007161 | |
| GeneOntologyBiologicalProcess | regulation of axon extension involved in regeneration | 9.09e-05 | 4 | 81 | 2 | GO:0048690 | |
| GeneOntologyBiologicalProcess | cell junction organization | FN1 NRXN2 SLIT1 LRP1 LAMA3 LRP4 LAMA5 LIMCH1 WNT4 TNR ITGB1 ITGB3 CDH11 | 1.02e-04 | 974 | 81 | 13 | GO:0034330 |
| GeneOntologyBiologicalProcess | negative regulation of axonogenesis | 1.04e-04 | 62 | 81 | 4 | GO:0050771 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter uptake | 1.11e-04 | 24 | 81 | 3 | GO:0051580 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | ARHGAP5 FBLN1 PHPT1 FN1 SEMA5B PDGFD LRP1 LAMB1 PDGFC ITGB1 ITGB3 | 1.21e-04 | 725 | 81 | 11 | GO:2000147 |
| GeneOntologyBiologicalProcess | hair follicle development | 1.24e-04 | 123 | 81 | 5 | GO:0001942 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | 1.32e-04 | 384 | 81 | 8 | GO:0032956 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 1.34e-04 | 385 | 81 | 8 | GO:0070372 | |
| GeneOntologyBiologicalProcess | molting cycle process | 1.39e-04 | 126 | 81 | 5 | GO:0022404 | |
| GeneOntologyBiologicalProcess | hair cycle process | 1.39e-04 | 126 | 81 | 5 | GO:0022405 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | USP6 FN1 LMCD1 PDGFD LRP1 NGFR LRP4 PRKN CCN2 LTF WNT4 SSTR4 PDGFC ITGB1 ITGB3 | 1.43e-04 | 1299 | 81 | 15 | GO:1902533 |
| GeneOntologyBiologicalProcess | axon extension involved in regeneration | 1.51e-04 | 5 | 81 | 2 | GO:0048677 | |
| GeneOntologyBiologicalProcess | regulation of sprouting of injured axon | 1.51e-04 | 5 | 81 | 2 | GO:0048686 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 1.52e-04 | 619 | 81 | 10 | GO:0002009 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | 1.57e-04 | 747 | 81 | 11 | GO:0007169 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to membrane | 1.61e-04 | 130 | 81 | 5 | GO:1905477 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 1.64e-04 | 296 | 81 | 7 | GO:0048762 | |
| GeneOntologyBiologicalProcess | cell growth | 1.65e-04 | 625 | 81 | 10 | GO:0016049 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 1.65e-04 | 625 | 81 | 10 | GO:0051960 | |
| GeneOntologyBiologicalProcess | platelet-derived growth factor receptor signaling pathway | 1.76e-04 | 71 | 81 | 4 | GO:0048008 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 1.86e-04 | 515 | 81 | 9 | GO:0050767 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | ARHGAP5 FBLN1 FN1 PDGFD NGFR LAMB1 ESM1 CCN2 LTF DLL1 PDGFC ITGB1 ITGB3 TNXB | 2.02e-04 | 1190 | 81 | 14 | GO:0008284 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 2.06e-04 | 74 | 81 | 4 | GO:0002011 | |
| GeneOntologyBiologicalProcess | central nervous system development | CELSR1 WNT3 SLIT1 LRP1 NGFR LAMB1 PRKN WNT4 SSTR4 DLL1 PDGFC TNR ITGB1 CDH11 | 2.15e-04 | 1197 | 81 | 14 | GO:0007417 |
| GeneOntologyBiologicalProcess | developmental growth | FN1 MEGF8 SEMA5B WNT3 SLIT1 TM4SF4 LRP1 LRP4 PRKN DLL1 TNR ITGB1 | 2.19e-04 | 911 | 81 | 12 | GO:0048589 |
| GeneOntologyBiologicalProcess | regulation of vascular endothelial growth factor signaling pathway | 2.19e-04 | 30 | 81 | 3 | GO:1900746 | |
| GeneOntologyBiologicalProcess | sprouting of injured axon | 2.26e-04 | 6 | 81 | 2 | GO:0048682 | |
| GeneOntologyCellularComponent | extracellular matrix | SNED1 ADAMTS19 FBLN1 ZAN FN1 MEGF6 ADAMTSL5 ADAMTS7 WNT3 NTN3 LAMA1 LAMA3 LAMA4 LAMA5 LAMB1 CCN2 ADAMTS8 ADAM11 WNT4 MUC2 TNR USH2A ITGB1 TNXB FBN3 OC90 | 1.13e-19 | 656 | 81 | 26 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | SNED1 ADAMTS19 FBLN1 ZAN FN1 MEGF6 ADAMTSL5 ADAMTS7 WNT3 NTN3 LAMA1 LAMA3 LAMA4 LAMA5 LAMB1 CCN2 ADAMTS8 ADAM11 WNT4 MUC2 TNR USH2A ITGB1 TNXB FBN3 OC90 | 1.21e-19 | 658 | 81 | 26 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | FBLN1 FN1 MEGF6 ADAMTSL5 NTN3 LAMA1 LAMA3 LAMA4 LAMA5 LAMB1 CCN2 ADAMTS8 ADAM11 MUC2 TNR USH2A ITGB1 TNXB | 1.47e-12 | 530 | 81 | 18 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 4.18e-11 | 122 | 81 | 10 | GO:0005604 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 6.74e-11 | 59 | 81 | 8 | GO:0098636 | |
| GeneOntologyCellularComponent | laminin complex | 4.32e-08 | 10 | 81 | 4 | GO:0043256 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 4.79e-07 | 17 | 81 | 4 | GO:0098637 | |
| GeneOntologyCellularComponent | integrin complex | 6.93e-06 | 32 | 81 | 4 | GO:0008305 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 4.37e-05 | 332 | 81 | 8 | GO:0005788 | |
| GeneOntologyCellularComponent | laminin-10 complex | 4.44e-05 | 3 | 81 | 2 | GO:0043259 | |
| GeneOntologyCellularComponent | extracellular matrix of synaptic cleft | 4.44e-05 | 3 | 81 | 2 | GO:0098965 | |
| GeneOntologyCellularComponent | laminin-1 complex | 4.44e-05 | 3 | 81 | 2 | GO:0005606 | |
| GeneOntologyCellularComponent | laminin-3 complex | 4.44e-05 | 3 | 81 | 2 | GO:0005608 | |
| GeneOntologyCellularComponent | integrin alpha9-beta1 complex | 4.44e-05 | 3 | 81 | 2 | GO:0034679 | |
| GeneOntologyCellularComponent | neuromuscular junction | 7.48e-05 | 112 | 81 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | cell surface | MELTF TNFRSF9 ADAMTS7 LRP1 NGFR LRP4 LTF WNT4 PDGFC TNR ITGB1 ITGB3 ITGB6 ITGB7 | 8.56e-05 | 1111 | 81 | 14 | GO:0009986 |
| GeneOntologyCellularComponent | laminin-5 complex | 8.85e-05 | 4 | 81 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | tenascin complex | 8.85e-05 | 4 | 81 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.89e-04 | 523 | 81 | 9 | GO:0098984 | |
| GeneOntologyCellularComponent | asymmetric synapse | 5.19e-04 | 477 | 81 | 8 | GO:0032279 | |
| GeneOntologyCellularComponent | hemidesmosome | 7.97e-04 | 11 | 81 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 1.13e-03 | 13 | 81 | 2 | GO:0099535 | |
| GeneOntologyCellularComponent | microfibril | 1.13e-03 | 13 | 81 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | anchoring junction | LAMA1 LRP1 NGFR LAMA3 DLL1 ITGB1 ITGB3 ITGB6 ITGB7 CDH11 CRB2 | 1.32e-03 | 976 | 81 | 11 | GO:0070161 |
| GeneOntologyCellularComponent | postsynaptic density | 1.83e-03 | 451 | 81 | 7 | GO:0014069 | |
| GeneOntologyCellularComponent | lamellipodium | 2.01e-03 | 230 | 81 | 5 | GO:0030027 | |
| GeneOntologyCellularComponent | cell-cell junction | 2.05e-03 | 591 | 81 | 8 | GO:0005911 | |
| GeneOntologyCellularComponent | glycinergic synapse | 2.69e-03 | 20 | 81 | 2 | GO:0098690 | |
| GeneOntologyCellularComponent | cell leading edge | 3.25e-03 | 500 | 81 | 7 | GO:0031252 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 3.36e-03 | 503 | 81 | 7 | GO:0099572 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 4.30e-03 | 817 | 81 | 9 | GO:0098978 | |
| GeneOntologyCellularComponent | synaptic cleft | 7.24e-03 | 33 | 81 | 2 | GO:0043083 | |
| GeneOntologyCellularComponent | synaptic membrane | 7.43e-03 | 583 | 81 | 7 | GO:0097060 | |
| GeneOntologyCellularComponent | cell-substrate junction | 7.46e-03 | 443 | 81 | 6 | GO:0030055 | |
| GeneOntologyCellularComponent | Golgi lumen | 8.76e-03 | 109 | 81 | 3 | GO:0005796 | |
| GeneOntologyCellularComponent | leading edge membrane | 9.02e-03 | 210 | 81 | 4 | GO:0031256 | |
| GeneOntologyCellularComponent | adherens junction | 9.31e-03 | 212 | 81 | 4 | GO:0005912 | |
| GeneOntologyCellularComponent | recycling endosome | 1.09e-02 | 222 | 81 | 4 | GO:0055037 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 1.10e-02 | 785 | 81 | 8 | GO:0098797 | |
| MousePheno | abnormal spinal nerve morphology | 1.81e-05 | 107 | 72 | 6 | MP:0001077 | |
| MousePheno | petechiae | 2.10e-05 | 11 | 72 | 3 | MP:0008816 | |
| MousePheno | abnormal respiration | ARHGAP5 FBLN1 PHPT1 ADAMTS7 CPEB4 NGFR LAMA3 LRP4 PRKN CCN2 SSTR4 ITGB6 | 4.92e-05 | 598 | 72 | 12 | MP:0001943 |
| MousePheno | abnormal jaw morphology | FBLN1 MEGF8 NSD2 NGFR LAMA3 LRP4 WNT10A LAMA5 CCN2 ITGB1 ITGB6 | 7.78e-05 | 530 | 72 | 11 | MP:0000454 |
| Domain | EGF_1 | TMEFF1 SNED1 FBLN1 NELL2 CELSR1 ZAN FN1 MEGF6 MEGF8 NRXN2 NTN3 SLIT1 LAMA1 LRP1 LAMA3 LAMA4 LRP4 LAMA5 LAMB1 ADAM33 ADAM11 C6 DLL1 TNR USH2A ITGB1 LRP1B ITGB3 TNXB ITGB6 ITGB7 MEGF11 FBN3 CRB2 | 1.05e-42 | 255 | 80 | 34 | PS00022 |
| Domain | EGF-like_CS | TMEFF1 SNED1 FBLN1 NELL2 CELSR1 ZAN FN1 MEGF6 MEGF8 NRXN2 NTN3 SLIT1 LAMA1 LRP1 LAMA3 LAMA4 LRP4 LAMA5 LAMB1 ADAM33 ADAM11 C6 DLL1 TNR ITGB1 LRP1B ITGB3 TNXB ITGB6 ITGB7 MEGF11 FBN3 CRB2 | 1.41e-40 | 261 | 80 | 33 | IPR013032 |
| Domain | EGF_2 | TMEFF1 SNED1 FBLN1 NELL2 CELSR1 ZAN MEGF6 MEGF8 NRXN2 NTN3 SLIT1 LAMA1 LRP1 LAMA3 LRP4 LAMA5 LAMB1 ADAM33 ADAM11 C6 DLL1 TNR LRP1B ITGB3 TNXB ITGB6 ITGB7 MEGF11 FBN3 CRB2 | 3.23e-35 | 265 | 80 | 30 | PS01186 |
| Domain | EGF-like_dom | TMEFF1 SNED1 FBLN1 NELL2 CELSR1 ZAN MEGF6 MEGF8 NRXN2 SLIT1 LAMA1 LRP1 LAMA3 LAMA4 LRP4 LAMA5 LAMB1 ADAM33 ADAM11 C6 DLL1 TNR LRP1B TNXB MEGF11 FBN3 CRB2 | 4.63e-31 | 249 | 80 | 27 | IPR000742 |
| Domain | EGF | TMEFF1 SNED1 FBLN1 NELL2 CELSR1 ZAN MEGF6 MEGF8 NRXN2 SLIT1 LAMA1 LRP1 LAMA3 LAMA4 LRP4 LAMA5 LAMB1 ADAM33 ADAM11 DLL1 TNR LRP1B TNXB MEGF11 FBN3 CRB2 | 4.06e-30 | 235 | 80 | 26 | SM00181 |
| Domain | Growth_fac_rcpt_ | FBLN1 NELL2 CELSR1 TNFRSF9 MEGF6 MEGF8 NTN3 SLIT1 LAMA1 LRP1 LAMA3 LRP4 LAMA5 LAMB1 ESM1 CCN2 DLL1 LRP1B TNXB FBN3 | 1.80e-24 | 156 | 80 | 20 | IPR009030 |
| Domain | EGF_3 | TMEFF1 SNED1 FBLN1 NELL2 CELSR1 ZAN MEGF6 MEGF8 NRXN2 SLIT1 LRP1 LRP4 ADAM33 ADAM11 C6 DLL1 TNR LRP1B TNXB MEGF11 FBN3 CRB2 | 8.23e-24 | 235 | 80 | 22 | PS50026 |
| Domain | Laminin_EGF | CELSR1 MEGF6 MEGF8 NTN3 LAMA1 LAMA3 LAMA4 LAMA5 LAMB1 USH2A MEGF11 | 1.67e-18 | 35 | 80 | 11 | PF00053 |
| Domain | EGF_Lam | CELSR1 MEGF6 MEGF8 NTN3 LAMA1 LAMA3 LAMA4 LAMA5 LAMB1 USH2A MEGF11 | 1.67e-18 | 35 | 80 | 11 | SM00180 |
| Domain | Laminin_EGF | CELSR1 MEGF6 MEGF8 NTN3 LAMA1 LAMA3 LAMA4 LAMA5 LAMB1 USH2A MEGF11 | 4.77e-18 | 38 | 80 | 11 | IPR002049 |
| Domain | EGF_extracell | NELL2 MEGF6 ADAM33 ADAM11 TNR ITGB1 LRP1B ITGB3 TNXB ITGB6 ITGB7 MEGF11 | 1.91e-17 | 60 | 80 | 12 | IPR013111 |
| Domain | EGF_2 | NELL2 MEGF6 ADAM33 ADAM11 TNR ITGB1 LRP1B ITGB3 TNXB ITGB6 ITGB7 MEGF11 | 1.91e-17 | 60 | 80 | 12 | PF07974 |
| Domain | EGF | SNED1 CELSR1 ZAN MEGF6 NRXN2 SLIT1 LRP1 LRP4 DLL1 LRP1B ITGB3 TNXB FBN3 CRB2 | 2.00e-16 | 126 | 80 | 14 | PF00008 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | SNED1 FBLN1 NELL2 CELSR1 MEGF6 MEGF8 SLIT1 LRP1 LRP4 DLL1 LRP1B FBN3 CRB2 | 6.83e-16 | 106 | 80 | 13 | IPR000152 |
| Domain | Laminin_G_2 | 8.87e-16 | 40 | 80 | 10 | PF02210 | |
| Domain | LamG | 2.56e-15 | 44 | 80 | 10 | SM00282 | |
| Domain | EGF_LAM_2 | 4.06e-15 | 30 | 80 | 9 | PS50027 | |
| Domain | EGF_LAM_1 | 4.06e-15 | 30 | 80 | 9 | PS01248 | |
| Domain | EGF_CA | SNED1 FBLN1 NELL2 CELSR1 MEGF6 MEGF8 SLIT1 LRP1 LRP4 DLL1 LRP1B FBN3 CRB2 | 4.47e-15 | 122 | 80 | 13 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | SNED1 FBLN1 NELL2 CELSR1 MEGF6 MEGF8 SLIT1 LRP1 LRP4 DLL1 LRP1B FBN3 CRB2 | 5.54e-15 | 124 | 80 | 13 | IPR001881 |
| Domain | EGF_Ca-bd_CS | SNED1 FBLN1 NELL2 MEGF6 MEGF8 SLIT1 LRP1 LRP4 DLL1 LRP1B FBN3 CRB2 | 8.60e-15 | 97 | 80 | 12 | IPR018097 |
| Domain | EGF_CA | SNED1 FBLN1 NELL2 MEGF6 MEGF8 SLIT1 LRP1 LRP4 DLL1 LRP1B FBN3 CRB2 | 1.11e-14 | 99 | 80 | 12 | PS01187 |
| Domain | ASX_HYDROXYL | SNED1 FBLN1 NELL2 CELSR1 MEGF6 MEGF8 LRP1 LRP4 DLL1 LRP1B FBN3 CRB2 | 1.25e-14 | 100 | 80 | 12 | PS00010 |
| Domain | LAM_G_DOMAIN | 4.50e-14 | 38 | 80 | 9 | PS50025 | |
| Domain | Laminin_G | 5.14e-14 | 58 | 80 | 10 | IPR001791 | |
| Domain | - | 8.76e-12 | 95 | 80 | 10 | 2.60.120.200 | |
| Domain | hEGF | 2.23e-11 | 28 | 80 | 7 | PF12661 | |
| Domain | Laminin_N | 3.95e-11 | 16 | 80 | 6 | IPR008211 | |
| Domain | LAMININ_NTER | 3.95e-11 | 16 | 80 | 6 | PS51117 | |
| Domain | Laminin_N | 3.95e-11 | 16 | 80 | 6 | PF00055 | |
| Domain | LamNT | 3.95e-11 | 16 | 80 | 6 | SM00136 | |
| Domain | Integin_beta_N | 1.58e-10 | 9 | 80 | 5 | IPR033760 | |
| Domain | PSI_integrin | 1.58e-10 | 9 | 80 | 5 | PF17205 | |
| Domain | Laminin_aI | 1.56e-09 | 5 | 80 | 4 | IPR009254 | |
| Domain | Laminin_I | 1.56e-09 | 5 | 80 | 4 | PF06008 | |
| Domain | Laminin_II | 1.56e-09 | 5 | 80 | 4 | PF06009 | |
| Domain | Laminin_domII | 1.56e-09 | 5 | 80 | 4 | IPR010307 | |
| Domain | ConA-like_dom | NELL2 CELSR1 ZAN NRXN2 SLIT1 LAMA1 LAMA3 LAMA4 LAMA5 USH2A CRB2 | 2.31e-09 | 219 | 80 | 11 | IPR013320 |
| Domain | EGF_CA | 3.21e-09 | 86 | 80 | 8 | PF07645 | |
| Domain | Integrin_bsu_cyt_dom | 4.65e-09 | 6 | 80 | 4 | IPR014836 | |
| Domain | Integrin_b_cyt | 4.65e-09 | 6 | 80 | 4 | SM01241 | |
| Domain | Integrin_b_cyt | 4.65e-09 | 6 | 80 | 4 | PF08725 | |
| Domain | TSP_1 | 9.23e-09 | 63 | 80 | 7 | PF00090 | |
| Domain | Integrin_bsu_tail | 1.08e-08 | 7 | 80 | 4 | IPR012896 | |
| Domain | Integrin_B_tail | 1.08e-08 | 7 | 80 | 4 | SM01242 | |
| Domain | Integrin_B_tail | 1.08e-08 | 7 | 80 | 4 | PF07965 | |
| Domain | TSP1 | 1.15e-08 | 65 | 80 | 7 | SM00209 | |
| Domain | TSP1_rpt | 1.15e-08 | 65 | 80 | 7 | IPR000884 | |
| Domain | TSP1 | 1.15e-08 | 65 | 80 | 7 | PS50092 | |
| Domain | Integrin_beta | 2.16e-08 | 8 | 80 | 4 | PF00362 | |
| Domain | INB | 2.16e-08 | 8 | 80 | 4 | SM00187 | |
| Domain | Integrin_bsu_VWA | 2.16e-08 | 8 | 80 | 4 | IPR002369 | |
| Domain | PSI | 3.16e-08 | 44 | 80 | 6 | IPR016201 | |
| Domain | Integrin_bsu | 3.87e-08 | 9 | 80 | 4 | IPR015812 | |
| Domain | INTEGRIN_BETA | 3.87e-08 | 9 | 80 | 4 | PS00243 | |
| Domain | PSI | 4.17e-08 | 46 | 80 | 6 | SM00423 | |
| Domain | cEGF | 7.79e-08 | 26 | 80 | 5 | IPR026823 | |
| Domain | cEGF | 7.79e-08 | 26 | 80 | 5 | PF12662 | |
| Domain | - | 3.02e-07 | 4 | 80 | 3 | 1.20.5.630 | |
| Domain | Peptidase_M12B_N | 6.53e-07 | 39 | 80 | 5 | IPR002870 | |
| Domain | Pep_M12B_propep | 6.53e-07 | 39 | 80 | 5 | PF01562 | |
| Domain | DISINTEGRIN_1 | 7.43e-07 | 40 | 80 | 5 | PS00427 | |
| Domain | Reprolysin | 7.43e-07 | 40 | 80 | 5 | PF01421 | |
| Domain | ADAM_MEPRO | 7.43e-07 | 40 | 80 | 5 | PS50215 | |
| Domain | DISINTEGRIN_2 | 7.43e-07 | 40 | 80 | 5 | PS50214 | |
| Domain | Peptidase_M12B | 7.43e-07 | 40 | 80 | 5 | IPR001590 | |
| Domain | Disintegrin_dom | 8.44e-07 | 41 | 80 | 5 | IPR001762 | |
| Domain | ADAM_spacer1 | 2.60e-06 | 23 | 80 | 4 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.60e-06 | 23 | 80 | 4 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.11e-06 | 24 | 80 | 4 | IPR013273 | |
| Domain | Integrin_dom | 3.69e-06 | 25 | 80 | 4 | IPR032695 | |
| Domain | LAMININ_IVA | 4.17e-06 | 8 | 80 | 3 | PS51115 | |
| Domain | Laminin_B | 4.17e-06 | 8 | 80 | 3 | PF00052 | |
| Domain | LamB | 4.17e-06 | 8 | 80 | 3 | SM00281 | |
| Domain | Laminin_IV | 4.17e-06 | 8 | 80 | 3 | IPR000034 | |
| Domain | ACR | 5.08e-06 | 27 | 80 | 4 | SM00608 | |
| Domain | ADAM_Cys-rich | 5.08e-06 | 27 | 80 | 4 | IPR006586 | |
| Domain | VWFC_1 | 1.66e-05 | 36 | 80 | 4 | PS01208 | |
| Domain | DUF5050 | 1.81e-05 | 2 | 80 | 2 | IPR032485 | |
| Domain | DUF5050 | 1.81e-05 | 2 | 80 | 2 | PF16472 | |
| Domain | VWC | 2.06e-05 | 38 | 80 | 4 | SM00214 | |
| Domain | VWFC_2 | 2.06e-05 | 38 | 80 | 4 | PS50184 | |
| Domain | MetalloPept_cat_dom | 2.52e-05 | 81 | 80 | 5 | IPR024079 | |
| Domain | - | 2.52e-05 | 81 | 80 | 5 | 3.40.390.10 | |
| Domain | LDLR_class-A_CS | 2.54e-05 | 40 | 80 | 4 | IPR023415 | |
| Domain | Ldl_recept_b | 2.66e-05 | 14 | 80 | 3 | PF00058 | |
| Domain | LDLRB | 2.66e-05 | 14 | 80 | 3 | PS51120 | |
| Domain | VWF_dom | 3.09e-05 | 42 | 80 | 4 | IPR001007 | |
| Domain | LY | 3.32e-05 | 15 | 80 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.32e-05 | 15 | 80 | 3 | IPR000033 | |
| Domain | Ldl_recept_a | 4.07e-05 | 45 | 80 | 4 | PF00057 | |
| Domain | LDLRA_1 | 5.26e-05 | 48 | 80 | 4 | PS01209 | |
| Domain | TRANSFERRIN_LIKE_1 | 5.42e-05 | 3 | 80 | 2 | PS00205 | |
| Domain | TRANSFERRIN_LIKE_2 | 5.42e-05 | 3 | 80 | 2 | PS00206 | |
| Domain | TRANSFERRIN_LIKE_3 | 5.42e-05 | 3 | 80 | 2 | PS00207 | |
| Domain | Transferrin_Fe_BS | 5.42e-05 | 3 | 80 | 2 | IPR018195 | |
| Domain | Transferrin | 5.42e-05 | 3 | 80 | 2 | PF00405 | |
| Domain | Transferrin | 5.42e-05 | 3 | 80 | 2 | IPR016357 | |
| Domain | TR_FER | 5.42e-05 | 3 | 80 | 2 | SM00094 | |
| Domain | Transferrin-like_dom | 5.42e-05 | 3 | 80 | 2 | IPR001156 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | FN1 LAMA1 LAMA3 LAMA4 LRP4 LAMA5 LAMB1 TNR ITGB1 ITGB3 TNXB ITGB6 | 6.40e-16 | 76 | 64 | 12 | M27219 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | FN1 LAMA1 LAMA3 LAMA4 LAMA5 LAMB1 TNR ITGB1 ITGB3 TNXB ITGB6 ITGB7 | 2.27e-15 | 84 | 64 | 12 | M7098 |
| Pathway | WP_FOCAL_ADHESION | ARHGAP5 FN1 PDGFD LAMA1 LAMA3 LAMA4 LAMA5 LAMB1 PDGFC TNR ITGB1 ITGB3 TNXB ITGB6 ITGB7 | 3.56e-15 | 187 | 64 | 15 | MM15913 |
| Pathway | WP_FOCAL_ADHESION | ARHGAP5 FN1 PDGFD LAMA1 LAMA3 LAMA4 LAMA5 LAMB1 PDGFC TNR ITGB1 ITGB3 TNXB ITGB6 ITGB7 | 9.01e-15 | 199 | 64 | 15 | M39402 |
| Pathway | KEGG_FOCAL_ADHESION | ARHGAP5 FN1 PDGFD LAMA1 LAMA3 LAMA4 LAMA5 LAMB1 PDGFC TNR ITGB1 ITGB3 TNXB ITGB6 ITGB7 | 9.01e-15 | 199 | 64 | 15 | M7253 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | FBLN1 FN1 LAMA1 LAMA3 LAMA4 LRP4 LAMA5 LAMB1 ADAMTS8 TNR ITGB1 ITGB3 TNXB ITGB6 ITGB7 FBN3 | 2.31e-13 | 300 | 64 | 16 | M610 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | FN1 PDGFD LAMA1 NGFR LAMA3 LAMA4 LAMA5 LAMB1 PDGFC TNR ITGB1 ITGB3 TNXB ITGB6 ITGB7 | 4.03e-12 | 302 | 64 | 15 | M39719 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | FN1 PDGFD LAMA1 NGFR LAMA3 LAMA4 LAMA5 LAMB1 PDGFC TNR ITGB1 ITGB3 TNXB ITGB6 ITGB7 | 1.20e-11 | 326 | 64 | 15 | MM15917 |
| Pathway | WP_PI3KAKT_SIGNALING | FN1 PDGFD LAMA1 NGFR LAMA3 LAMA4 LAMA5 LAMB1 PDGFC TNR ITGB1 ITGB3 TNXB ITGB6 ITGB7 | 2.10e-11 | 339 | 64 | 15 | M39736 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 5.32e-11 | 30 | 64 | 7 | M27772 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | FN1 WNT3 PDGFD LAMA1 NGFR LAMA3 LAMA4 WNT10A LAMA5 LAMB1 CCN2 WNT4 PDGFC ITGB1 ITGB3 CDH11 | 7.39e-11 | 439 | 64 | 16 | M42563 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.12e-10 | 59 | 64 | 8 | M27218 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.65e-10 | 41 | 64 | 7 | M27778 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.76e-09 | 30 | 64 | 6 | M27216 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.43e-08 | 37 | 64 | 6 | M27134 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.79e-08 | 66 | 64 | 7 | M18 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.25e-08 | 44 | 64 | 6 | M26969 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 5.20e-08 | 23 | 64 | 5 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 5.20e-08 | 23 | 64 | 5 | M47720 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 5.60e-08 | 46 | 64 | 6 | M239 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 6.36e-08 | 79 | 64 | 7 | M27643 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.40e-08 | 47 | 64 | 6 | MM14925 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 9.77e-08 | 84 | 64 | 7 | M3228 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 1.01e-07 | 26 | 64 | 5 | M47719 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.24e-07 | 11 | 64 | 4 | M158 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 1.49e-07 | 28 | 64 | 5 | M47655 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 2.15e-07 | 30 | 64 | 5 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 2.15e-07 | 30 | 64 | 5 | M47718 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 2.46e-07 | 96 | 64 | 7 | M39834 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 8.41e-07 | 39 | 64 | 5 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 8.41e-07 | 39 | 64 | 5 | MM15165 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 1.19e-06 | 121 | 64 | 7 | M39823 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 1.23e-06 | 42 | 64 | 5 | M174 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.42e-06 | 19 | 64 | 4 | MM15512 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 1.86e-06 | 325 | 64 | 10 | M12868 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.29e-06 | 258 | 64 | 9 | MM14572 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 5.36e-06 | 26 | 64 | 4 | M47 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 9.69e-06 | 30 | 64 | 4 | MM15517 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 9.69e-06 | 109 | 64 | 6 | MM15164 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.11e-05 | 31 | 64 | 4 | MM1343 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 1.26e-05 | 32 | 64 | 4 | M165 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.26e-05 | 32 | 64 | 4 | MM14854 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.38e-05 | 68 | 64 | 5 | M27303 | |
| Pathway | PID_SYNDECAN_2_PATHWAY | 1.43e-05 | 33 | 64 | 4 | M240 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.43e-05 | 33 | 64 | 4 | M39503 | |
| Pathway | WP_CANCER_PATHWAYS | FN1 WNT3 LAMA1 LAMA3 LAMA4 WNT10A LAMA5 LAMB1 WNT4 DLL1 ITGB1 | 1.54e-05 | 507 | 64 | 11 | M48302 |
| Pathway | WP_AXON_GUIDANCE | 1.82e-05 | 72 | 64 | 5 | M48335 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.37e-05 | 76 | 64 | 5 | MM14867 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.82e-05 | 39 | 64 | 4 | MM14601 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 3.13e-05 | 14 | 64 | 3 | MM14923 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.91e-05 | 15 | 64 | 3 | MM14922 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.02e-05 | 140 | 64 | 6 | M587 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.08e-05 | 85 | 64 | 5 | M16441 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 4.17e-05 | 43 | 64 | 4 | M39565 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 4.17e-05 | 43 | 64 | 4 | M53 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 4.58e-05 | 44 | 64 | 4 | MM15878 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 4.88e-05 | 213 | 64 | 7 | M18306 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 5.80e-05 | 17 | 64 | 3 | M212 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 5.95e-05 | 47 | 64 | 4 | M39829 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 8.21e-05 | 19 | 64 | 3 | M47836 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.30e-04 | 532 | 64 | 10 | M27870 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.46e-04 | 111 | 64 | 5 | M27416 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 1.91e-04 | 25 | 64 | 3 | MM14940 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 2.15e-04 | 26 | 64 | 3 | M27239 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 2.25e-04 | 66 | 64 | 4 | MM15925 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.39e-04 | 67 | 64 | 4 | MM15345 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 2.42e-04 | 27 | 64 | 3 | M27217 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR | 2.70e-04 | 28 | 64 | 3 | M47835 | |
| Pathway | KEGG_AXON_GUIDANCE | 2.94e-04 | 129 | 64 | 5 | M5539 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY | 3.00e-04 | 29 | 64 | 3 | M47372 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY | 3.00e-04 | 29 | 64 | 3 | M47377 | |
| Pathway | REACTOME_FIBRONECTIN_MATRIX_FORMATION | 3.01e-04 | 6 | 64 | 2 | M26970 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 3.32e-04 | 30 | 64 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 3.32e-04 | 30 | 64 | 3 | MM15812 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 3.32e-04 | 73 | 64 | 4 | MM15126 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 3.50e-04 | 74 | 64 | 4 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 3.50e-04 | 74 | 64 | 4 | M16376 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.03e-04 | 32 | 64 | 3 | MM14924 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 4.42e-04 | 33 | 64 | 3 | M6220 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 4.72e-04 | 143 | 64 | 5 | M27275 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 5.43e-04 | 83 | 64 | 4 | M8728 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_FUNCTION | 5.58e-04 | 8 | 64 | 2 | MM17072 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 5.73e-04 | 36 | 64 | 3 | M39699 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 6.21e-04 | 37 | 64 | 3 | M47411 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 6.72e-04 | 38 | 64 | 3 | MM14874 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 7.37e-04 | 90 | 64 | 4 | M835 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 8.09e-04 | 161 | 64 | 5 | M39770 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 8.68e-04 | 94 | 64 | 4 | M1041 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 8.92e-04 | 10 | 64 | 2 | M27348 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 9.39e-04 | 96 | 64 | 4 | M39581 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 9.39e-04 | 96 | 64 | 4 | MM14592 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_FUNCTION | 1.09e-03 | 11 | 64 | 2 | M48015 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 1.11e-03 | 45 | 64 | 3 | M47412 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.18e-03 | 102 | 64 | 4 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.18e-03 | 102 | 64 | 4 | MM15830 | |
| Pathway | REACTOME_KIDNEY_DEVELOPMENT | 1.18e-03 | 46 | 64 | 3 | M48243 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 1.18e-03 | 46 | 64 | 3 | M47409 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.25e-03 | 47 | 64 | 3 | M646 | |
| Pathway | BIOCARTA_PRION_PATHWAY | 1.30e-03 | 12 | 64 | 2 | M22020 | |
| Pathway | BIOCARTA_UCALPAIN_PATHWAY | 1.30e-03 | 12 | 64 | 2 | MM1525 | |
| Pubmed | 1.12e-12 | 16 | 82 | 6 | 17601529 | ||
| Pubmed | 2.59e-12 | 18 | 82 | 6 | 11311202 | ||
| Pubmed | 3.58e-12 | 8 | 82 | 5 | 19633172 | ||
| Pubmed | 9.98e-12 | 75 | 82 | 8 | 20637190 | ||
| Pubmed | Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. | 1.61e-11 | 10 | 82 | 5 | 18590826 | |
| Pubmed | 1.61e-11 | 10 | 82 | 5 | 9034910 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 2.94e-11 | 11 | 82 | 5 | 21524702 | |
| Pubmed | 3.16e-11 | 26 | 82 | 6 | 24742657 | ||
| Pubmed | 5.03e-11 | 12 | 82 | 5 | 9396756 | ||
| Pubmed | 6.48e-11 | 29 | 82 | 6 | 22613833 | ||
| Pubmed | Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney. | 1.43e-10 | 5 | 82 | 4 | 9415429 | |
| Pubmed | Differential expression of laminin alpha chains during murine tooth development. | 1.43e-10 | 5 | 82 | 4 | 9389447 | |
| Pubmed | 1.74e-10 | 64 | 82 | 7 | 22261194 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 1.90e-10 | 15 | 82 | 5 | 12921739 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 1.90e-10 | 15 | 82 | 5 | 15895400 | |
| Pubmed | 2.37e-10 | 167 | 82 | 9 | 22159717 | ||
| Pubmed | Beta1-integrins are critical for cerebellar granule cell precursor proliferation. | 3.90e-10 | 17 | 82 | 5 | 15056720 | |
| Pubmed | 3.99e-10 | 118 | 82 | 8 | 21078624 | ||
| Pubmed | 4.29e-10 | 6 | 82 | 4 | 9597096 | ||
| Pubmed | 5.13e-10 | 40 | 82 | 6 | 27068110 | ||
| Pubmed | 9.71e-10 | 20 | 82 | 5 | 22911573 | ||
| Pubmed | 9.99e-10 | 7 | 82 | 4 | 8798654 | ||
| Pubmed | 9.99e-10 | 7 | 82 | 4 | 14557481 | ||
| Pubmed | Schwann cell myelination requires integration of laminin activities. | 1.27e-09 | 21 | 82 | 5 | 22767514 | |
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 1.99e-09 | 8 | 82 | 4 | 9489770 | |
| Pubmed | 1.99e-09 | 8 | 82 | 4 | 8872465 | ||
| Pubmed | 1.99e-09 | 8 | 82 | 4 | 9852162 | ||
| Pubmed | 1.99e-09 | 8 | 82 | 4 | 19651211 | ||
| Pubmed | Sox9 plays multiple roles in the lung epithelium during branching morphogenesis. | 2.09e-09 | 50 | 82 | 6 | 24191021 | |
| Pubmed | 2.09e-09 | 50 | 82 | 6 | 23658023 | ||
| Pubmed | Estrogen-dependent uterine secretion of osteopontin activates blastocyst adhesion competence. | 2.10e-09 | 23 | 82 | 5 | 23152823 | |
| Pubmed | Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. | 3.30e-09 | 25 | 82 | 5 | 19373938 | |
| Pubmed | 3.58e-09 | 9 | 82 | 4 | 9693030 | ||
| Pubmed | 3.58e-09 | 9 | 82 | 4 | 9882526 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 4.07e-09 | 26 | 82 | 5 | 34189436 | |
| Pubmed | 5.96e-09 | 10 | 82 | 4 | 11784026 | ||
| Pubmed | Integrin alpha6beta1-laminin interactions regulate early myotome formation in the mouse embryo. | 5.96e-09 | 10 | 82 | 4 | 16554364 | |
| Pubmed | 9.08e-09 | 175 | 82 | 8 | 28071719 | ||
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 9.35e-09 | 11 | 82 | 4 | 23472759 | |
| Pubmed | 9.35e-09 | 11 | 82 | 4 | 12051813 | ||
| Pubmed | 1.23e-08 | 32 | 82 | 5 | 23154389 | ||
| Pubmed | Endothelial basement membrane laminin 511 is essential for shear stress response. | 1.26e-08 | 3 | 82 | 3 | 27940654 | |
| Pubmed | Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. | 1.26e-08 | 3 | 82 | 3 | 11792823 | |
| Pubmed | Immunohistochemical localization of extracellular matrix proteins in developing lung tissues. | 1.26e-08 | 3 | 82 | 3 | 17334455 | |
| Pubmed | Laminin isoform-specific promotion of adhesion and migration of human bone marrow progenitor cells. | 1.26e-08 | 3 | 82 | 3 | 12393739 | |
| Pubmed | α1- and α5-containing laminins regulate the development of bile ducts via β1 integrin signals. | 1.26e-08 | 3 | 82 | 3 | 22761447 | |
| Pubmed | 1.26e-08 | 3 | 82 | 3 | 1382574 | ||
| Pubmed | 1.40e-08 | 12 | 82 | 4 | 11381080 | ||
| Pubmed | 1.40e-08 | 12 | 82 | 4 | 16750824 | ||
| Pubmed | Expression of laminin receptors in schwann cell differentiation: evidence for distinct roles. | 1.40e-08 | 12 | 82 | 4 | 12843252 | |
| Pubmed | 2.02e-08 | 13 | 82 | 4 | 36350252 | ||
| Pubmed | Fukutin-related protein alters the deposition of laminin in the eye and brain. | 2.02e-08 | 13 | 82 | 4 | 21900571 | |
| Pubmed | 2.02e-08 | 13 | 82 | 4 | 12682087 | ||
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 2.64e-08 | 37 | 82 | 5 | 34323105 | |
| Pubmed | 2.82e-08 | 14 | 82 | 4 | 9151674 | ||
| Pubmed | 2.82e-08 | 14 | 82 | 4 | 36347239 | ||
| Pubmed | 2.82e-08 | 14 | 82 | 4 | 19783738 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 3.46e-08 | 79 | 82 | 6 | 18757743 | |
| Pubmed | Epithelial-Macrophage Crosstalk Initiates Sterile Inflammation in Embryonic Skin. | 3.84e-08 | 15 | 82 | 4 | 34721382 | |
| Pubmed | 3.84e-08 | 15 | 82 | 4 | 10625553 | ||
| Pubmed | 3.84e-08 | 15 | 82 | 4 | 9264260 | ||
| Pubmed | Expression of laminin chains by central neurons: analysis with gene and protein trapping techniques. | 5.04e-08 | 4 | 82 | 3 | 12820173 | |
| Pubmed | 5.04e-08 | 4 | 82 | 3 | 19752234 | ||
| Pubmed | 5.04e-08 | 4 | 82 | 3 | 18611961 | ||
| Pubmed | Laminin-1 reexpression in Alport mouse glomerular basement membranes. | 5.04e-08 | 4 | 82 | 3 | 12631063 | |
| Pubmed | 5.04e-08 | 4 | 82 | 3 | 21325030 | ||
| Pubmed | 5.04e-08 | 4 | 82 | 3 | 9299121 | ||
| Pubmed | 5.04e-08 | 4 | 82 | 3 | 9201115 | ||
| Pubmed | Integrin requirement for hippocampal synaptic plasticity and spatial memory. | 5.11e-08 | 16 | 82 | 4 | 12904471 | |
| Pubmed | Mesenchymal-epithelial crosstalk shapes intestinal regionalisation via Wnt and Shh signalling. | 5.11e-08 | 16 | 82 | 4 | 35132078 | |
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 5.11e-08 | 16 | 82 | 4 | 17948866 | |
| Pubmed | Cell-matrix signals specify bone endothelial cells during developmental osteogenesis. | 5.11e-08 | 16 | 82 | 4 | 28218908 | |
| Pubmed | 5.11e-08 | 16 | 82 | 4 | 30579834 | ||
| Pubmed | Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation. | 5.11e-08 | 16 | 82 | 4 | 21067603 | |
| Pubmed | 5.81e-08 | 146 | 82 | 7 | 27068509 | ||
| Pubmed | 6.67e-08 | 17 | 82 | 4 | 21983115 | ||
| Pubmed | 6.67e-08 | 17 | 82 | 4 | 18082680 | ||
| Pubmed | 8.01e-08 | 153 | 82 | 7 | 25037231 | ||
| Pubmed | TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts. | 8.56e-08 | 18 | 82 | 4 | 23041440 | |
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 8.56e-08 | 18 | 82 | 4 | 39040056 | |
| Pubmed | 1.26e-07 | 5 | 82 | 3 | 11969289 | ||
| Pubmed | 1.26e-07 | 5 | 82 | 3 | 16457822 | ||
| Pubmed | 1.26e-07 | 5 | 82 | 3 | 19843520 | ||
| Pubmed | 1.26e-07 | 5 | 82 | 3 | 10964500 | ||
| Pubmed | 1.26e-07 | 5 | 82 | 3 | 19469865 | ||
| Pubmed | 1.26e-07 | 5 | 82 | 3 | 9719032 | ||
| Pubmed | 1.26e-07 | 5 | 82 | 3 | 8120056 | ||
| Pubmed | 1.26e-07 | 5 | 82 | 3 | 7544312 | ||
| Pubmed | 1.26e-07 | 5 | 82 | 3 | 12743034 | ||
| Pubmed | 1.26e-07 | 5 | 82 | 3 | 11829758 | ||
| Pubmed | 1.26e-07 | 5 | 82 | 3 | 7851641 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.35e-07 | 248 | 82 | 8 | 24006456 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.51e-07 | 101 | 82 | 6 | 23382219 | |
| Pubmed | 1.67e-07 | 21 | 82 | 4 | 19806668 | ||
| Pubmed | 1.77e-07 | 257 | 82 | 8 | 16335952 | ||
| Pubmed | USP6 FBLN1 NELL2 PHPT1 MEGF6 MEGF8 SLIT1 LAMB1 ADAM33 MEGF11 MIEF2 | 1.94e-07 | 608 | 82 | 11 | 16713569 | |
| Pubmed | 2.03e-07 | 22 | 82 | 4 | 28334989 | ||
| Pubmed | Ethanol increases fetal human neurosphere size and alters adhesion molecule gene expression. | 2.51e-07 | 6 | 82 | 3 | 18162078 | |
| Pubmed | Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth. | 2.51e-07 | 6 | 82 | 3 | 19118221 | |
| Pubmed | Laminin-10 and Lutheran blood group glycoproteins in adhesion of human endothelial cells. | 2.51e-07 | 6 | 82 | 3 | 16236823 | |
| Interaction | IGFL3 interactions | 1.76e-11 | 75 | 81 | 9 | int:IGFL3 | |
| Interaction | FBXO2 interactions | SNED1 NELL2 FN1 MEGF8 ADAMTS7 LAMA1 LAMA3 LAMA4 LAMA5 LAMB1 ADAM33 ITGB1 LRP1B | 9.34e-09 | 411 | 81 | 13 | int:FBXO2 |
| Interaction | PLAT interactions | 1.98e-07 | 63 | 81 | 6 | int:PLAT | |
| Interaction | ATXN7 interactions | 2.79e-07 | 109 | 81 | 7 | int:ATXN7 | |
| Interaction | SLURP1 interactions | 1.84e-06 | 144 | 81 | 7 | int:SLURP1 | |
| Interaction | ZFP41 interactions | 3.29e-06 | 57 | 81 | 5 | int:ZFP41 | |
| Interaction | MANEA interactions | 4.25e-06 | 60 | 81 | 5 | int:MANEA | |
| Interaction | FBLN2 interactions | 6.83e-06 | 66 | 81 | 5 | int:FBLN2 | |
| Interaction | CACNA1A interactions | 1.02e-05 | 123 | 81 | 6 | int:CACNA1A | |
| Interaction | CBLN4 interactions | 1.23e-05 | 127 | 81 | 6 | int:CBLN4 | |
| Interaction | HOXA1 interactions | 1.29e-05 | 356 | 81 | 9 | int:HOXA1 | |
| Interaction | TIMP2 interactions | 1.56e-05 | 277 | 81 | 8 | int:TIMP2 | |
| Interaction | CCN3 interactions | 1.61e-05 | 38 | 81 | 4 | int:CCN3 | |
| Interaction | NGF interactions | 1.74e-05 | 13 | 81 | 3 | int:NGF | |
| Interaction | IQGAP1 interactions | TRIM33 ABLIM1 NCAPG FN1 NSD2 PRKN LIMCH1 LTF ITGB1 WDFY4 ITGB3 | 2.37e-05 | 591 | 81 | 11 | int:IQGAP1 |
| Interaction | NID2 interactions | 2.50e-05 | 86 | 81 | 5 | int:NID2 | |
| Interaction | SIRPD interactions | 2.50e-05 | 86 | 81 | 5 | int:SIRPD | |
| Interaction | ELSPBP1 interactions | 3.46e-05 | 92 | 81 | 5 | int:ELSPBP1 | |
| Interaction | FGA interactions | 4.04e-05 | 95 | 81 | 5 | int:FGA | |
| Interaction | HSPG2 interactions | 4.69e-05 | 98 | 81 | 5 | int:HSPG2 | |
| Interaction | MFAP5 interactions | 5.66e-05 | 52 | 81 | 4 | int:MFAP5 | |
| Interaction | TRGV3 interactions | 7.07e-05 | 55 | 81 | 4 | int:TRGV3 | |
| Interaction | EDN3 interactions | 7.46e-05 | 108 | 81 | 5 | int:EDN3 | |
| Interaction | PTPRK interactions | 7.93e-05 | 177 | 81 | 6 | int:PTPRK | |
| Interaction | LYPD1 interactions | 8.71e-05 | 58 | 81 | 4 | int:LYPD1 | |
| Interaction | PSG3 interactions | 9.12e-05 | 22 | 81 | 3 | int:PSG3 | |
| Interaction | ATN1 interactions | 1.07e-04 | 187 | 81 | 6 | int:ATN1 | |
| Interaction | MEP1A interactions | 1.19e-04 | 24 | 81 | 3 | int:MEP1A | |
| Interaction | COL7A1 interactions | 1.35e-04 | 25 | 81 | 3 | int:COL7A1 | |
| Interaction | OIT3 interactions | 1.36e-04 | 65 | 81 | 4 | int:OIT3 | |
| Interaction | CFC1 interactions | 1.55e-04 | 126 | 81 | 5 | int:CFC1 | |
| Interaction | NTF3 interactions | 1.71e-04 | 27 | 81 | 3 | int:NTF3 | |
| Interaction | C1QTNF7 interactions | 1.72e-04 | 69 | 81 | 4 | int:C1QTNF7 | |
| Interaction | FBLN1 interactions | 1.73e-04 | 129 | 81 | 5 | int:FBLN1 | |
| Interaction | TAFAZZIN interactions | 1.87e-04 | 207 | 81 | 6 | int:TAFAZZIN | |
| Interaction | FIBIN interactions | 1.92e-04 | 71 | 81 | 4 | int:FIBIN | |
| Interaction | GFI1B interactions | 2.21e-04 | 136 | 81 | 5 | int:GFI1B | |
| Interaction | COL4A3 interactions | 2.35e-04 | 30 | 81 | 3 | int:COL4A3 | |
| Interaction | SIGLEC1 interactions | 2.37e-04 | 6 | 81 | 2 | int:SIGLEC1 | |
| Interaction | LY86 interactions | 2.41e-04 | 217 | 81 | 6 | int:LY86 | |
| Interaction | CRP interactions | 2.62e-04 | 77 | 81 | 4 | int:CRP | |
| Interaction | FLNA interactions | 2.65e-04 | 648 | 81 | 10 | int:FLNA | |
| Interaction | SCGB2A2 interactions | 2.79e-04 | 223 | 81 | 6 | int:SCGB2A2 | |
| Interaction | MSTN interactions | 3.13e-04 | 33 | 81 | 3 | int:MSTN | |
| Interaction | FCN1 interactions | 3.13e-04 | 33 | 81 | 3 | int:FCN1 | |
| Interaction | SDF2L1 interactions | 3.15e-04 | 322 | 81 | 7 | int:SDF2L1 | |
| Interaction | PLEC interactions | 3.32e-04 | 430 | 81 | 8 | int:PLEC | |
| Interaction | LTF interactions | 3.58e-04 | 151 | 81 | 5 | int:LTF | |
| Interaction | DYRK1A interactions | 3.68e-04 | 552 | 81 | 9 | int:DYRK1A | |
| Interaction | TGM2 interactions | 3.69e-04 | 235 | 81 | 6 | int:TGM2 | |
| Interaction | BCAN interactions | 4.06e-04 | 36 | 81 | 3 | int:BCAN | |
| Interaction | GGH interactions | 4.41e-04 | 243 | 81 | 6 | int:GGH | |
| GeneFamily | Laminin subunits | 2.22e-10 | 12 | 58 | 5 | 626 | |
| GeneFamily | CD molecules|Integrin beta subunits | 1.19e-08 | 9 | 58 | 4 | 1159 | |
| GeneFamily | Low density lipoprotein receptors | 8.76e-06 | 13 | 58 | 3 | 634 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.93e-05 | 19 | 58 | 3 | 50 | |
| GeneFamily | Wnt family|Endogenous ligands | 2.93e-05 | 19 | 58 | 3 | 360 | |
| GeneFamily | Transferrins | 3.03e-05 | 3 | 58 | 2 | 908 | |
| GeneFamily | Fibronectin type III domain containing | 1.60e-04 | 160 | 58 | 5 | 555 | |
| GeneFamily | LIM domain containing | 8.97e-04 | 59 | 58 | 3 | 1218 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.60e-03 | 394 | 58 | 6 | 471 | |
| GeneFamily | Fibrinogen C domain containing | 2.89e-03 | 25 | 58 | 2 | 554 | |
| GeneFamily | PHD finger proteins | 3.02e-03 | 90 | 58 | 3 | 88 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.37e-03 | 27 | 58 | 2 | 47 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 3.88e-03 | 29 | 58 | 2 | 782 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.44e-02 | 57 | 58 | 2 | 1179 | |
| Coexpression | NABA_MATRISOME | SNED1 ADAMTS19 FBLN1 NELL2 FN1 MEGF6 MEGF8 ADAMTSL5 SEMA5B ADAMTS7 WNT3 NTN3 PDGFD SLIT1 LAMA1 LAMA3 LAMA4 WNT10A LAMA5 LAMB1 ESM1 ADAM33 CCN2 ADAMTS8 ADAM11 WNT4 PDGFC MUC2 TNR USH2A TNXB MEGF11 FBN3 | 3.14e-25 | 1026 | 82 | 33 | M5889 |
| Coexpression | NABA_MATRISOME | SNED1 ADAMTS19 FBLN1 NELL2 FN1 MEGF6 MEGF8 ADAMTSL5 SEMA5B ADAMTS7 WNT3 NTN3 PDGFD SLIT1 LAMA1 LAMA3 LAMA4 WNT10A LAMA5 LAMB1 ESM1 ADAM33 CCN2 ADAMTS8 ADAM11 WNT4 PDGFC MUC2 TNR TNXB MEGF11 EGFEM1P | 3.06e-24 | 1008 | 82 | 32 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | SNED1 FBLN1 NELL2 FN1 NTN3 SLIT1 LAMA1 LAMA3 LAMA4 LAMA5 LAMB1 CCN2 TNR USH2A TNXB FBN3 | 1.39e-18 | 196 | 82 | 16 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | SNED1 FBLN1 NELL2 FN1 NTN3 SLIT1 LAMA1 LAMA3 LAMA4 LAMA5 LAMB1 ESM1 CCN2 TNR USH2A TNXB FBN3 | 1.21e-17 | 275 | 82 | 17 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | SNED1 FBLN1 NELL2 FN1 NTN3 SLIT1 LAMA1 LAMA3 LAMA4 LAMA5 LAMB1 CCN2 TNR TNXB EGFEM1P | 3.23e-17 | 191 | 82 | 15 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | SNED1 FBLN1 NELL2 FN1 NTN3 SLIT1 LAMA1 LAMA3 LAMA4 LAMA5 LAMB1 ESM1 CCN2 TNR TNXB EGFEM1P | 2.34e-16 | 270 | 82 | 16 | MM17057 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.87e-11 | 40 | 82 | 7 | M5887 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS19 MEGF6 MEGF8 ADAMTSL5 SEMA5B ADAMTS7 WNT3 PDGFD WNT10A ADAM33 ADAMTS8 ADAM11 WNT4 PDGFC MUC2 MEGF11 | 9.83e-10 | 738 | 82 | 16 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS19 MEGF6 MEGF8 ADAMTSL5 SEMA5B ADAMTS7 WNT3 PDGFD WNT10A ADAM33 ADAMTS8 ADAM11 WNT4 PDGFC MUC2 MEGF11 | 1.26e-09 | 751 | 82 | 16 | M5885 |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.33e-08 | 200 | 82 | 9 | M5930 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 7.53e-07 | 23 | 82 | 4 | M48001 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 8.46e-07 | 164 | 82 | 7 | M41676 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 2.14e-06 | 120 | 82 | 6 | M42505 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | NELL2 CELSR1 SEMA5B LMCD1 SLIT1 LRP1 LAMA4 ADAM33 CCN2 LIMCH1 CRB2 | 2.66e-06 | 600 | 82 | 11 | M39055 |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_DN | 2.87e-06 | 197 | 82 | 7 | M9910 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP | 3.07e-06 | 284 | 82 | 8 | M16975 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 3.30e-06 | 385 | 82 | 9 | M39264 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | SNED1 FBLN1 PDGFD LRP1 LAMA4 LAMA5 ADAM33 LIMCH1 PDGFC CDH11 | 3.99e-06 | 505 | 82 | 10 | M39167 |
| Coexpression | HAY_BONE_MARROW_STROMAL | FBLN1 FN1 NRXN2 LMCD1 NGFR LAMA4 ESM1 CCN2 LIMCH1 WNT4 ITGB6 CDH11 | 4.59e-06 | 767 | 82 | 12 | M39209 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | SNED1 ADAMTS19 FN1 ADAMTSL5 SEMA5B ADAMTS7 PDGFD LAMA1 WNT10A LAMB1 CCN2 ADAMTS8 WNT4 MEGF11 | 5.64e-06 | 1074 | 82 | 14 | M1941 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | SLC26A8 RNH1 ADAMTSL5 NRXN2 WNT3 PDGFD SLIT1 CCN2 SSTR4 TNXB | 7.66e-06 | 544 | 82 | 10 | M1936 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | 7.70e-06 | 322 | 82 | 8 | M39060 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | NELL2 MEGF6 NRXN2 ZNF174 PDGFD LAMA3 LAMA5 ADAM33 ADAMTS8 PDGFC TNXB FBN3 CRB2 | 8.00e-06 | 955 | 82 | 13 | M45680 |
| Coexpression | NABA_SECRETED_FACTORS | 1.09e-05 | 338 | 82 | 8 | MM17064 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 1.21e-05 | 162 | 82 | 6 | M45037 | |
| Coexpression | NABA_SECRETED_FACTORS | 1.22e-05 | 343 | 82 | 8 | M5883 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | SLC26A8 RNH1 ADAMTSL5 NRXN2 WNT3 PDGFD SLIT1 CCN2 SSTR4 TNXB | 1.22e-05 | 574 | 82 | 10 | MM820 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | ARHGAP5 CELSR1 LMCD1 SLIT1 LRP1 CCN2 LIMCH1 PDGFC LRP1B CRB2 | 1.22e-05 | 574 | 82 | 10 | M39056 |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 1.47e-05 | 352 | 82 | 8 | M17471 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.90e-05 | 479 | 82 | 9 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.03e-05 | 483 | 82 | 9 | MM1082 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | 2.56e-05 | 185 | 82 | 6 | M42503 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 3.15e-05 | 192 | 82 | 6 | M42501 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 3.24e-05 | 20 | 82 | 3 | MM17053 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 3.37e-05 | 117 | 82 | 5 | M39300 | |
| Coexpression | GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_DN | 3.44e-05 | 195 | 82 | 6 | M9309 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 4.66e-05 | 303 | 82 | 7 | M39040 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 4.93e-05 | 208 | 82 | 6 | M39233 | |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 5.79e-05 | 131 | 82 | 5 | M39232 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 7.12e-05 | 440 | 82 | 8 | M39039 | |
| Coexpression | LINDVALL_IMMORTALIZED_BY_TERT_DN | 8.22e-05 | 73 | 82 | 4 | M1561 | |
| Coexpression | DESCARTES_ORGANOGENESIS_CHOLINERGIC_NEURONS | 9.62e-05 | 76 | 82 | 4 | MM3658 | |
| Coexpression | NABA_ECM_REGULATORS | 1.04e-04 | 238 | 82 | 6 | M3468 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | CELSR1 RNH1 SEMA5B WNT3 NTN3 TM4SF4 WNT10A ADAMTS8 PDGFC ITGB6 OC90 | 1.10e-04 | 899 | 82 | 11 | M2242 |
| Coexpression | NABA_ECM_REGULATORS | 1.13e-04 | 242 | 82 | 6 | MM17062 | |
| Coexpression | PKCA_DN.V1_DN | 1.24e-04 | 154 | 82 | 5 | M2754 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | 1.46e-04 | 364 | 82 | 7 | M39057 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | CELSR1 RNH1 SEMA5B WNT3 NTN3 TM4SF4 WNT10A ADAMTS8 PDGFC ITGB6 OC90 | 1.48e-04 | 930 | 82 | 11 | MM893 |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 1.50e-04 | 33 | 82 | 3 | M9167 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 1.56e-04 | 493 | 82 | 8 | M19391 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 1.57e-04 | 257 | 82 | 6 | M13867 | |
| Coexpression | SCHOEN_NFKB_SIGNALING | 1.65e-04 | 34 | 82 | 3 | M1983 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 1.71e-04 | 261 | 82 | 6 | M1834 | |
| Coexpression | LIU_VAV3_PROSTATE_CARCINOGENESIS_UP | 1.77e-04 | 89 | 82 | 4 | M215 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.80e-04 | 35 | 82 | 3 | MM17054 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | 1.81e-04 | 504 | 82 | 8 | M2157 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | SNED1 ARHGAP5 ABLIM1 FBLN1 PDGFD MTMR3 LAMA4 CCN2 LIMCH1 ARL5A | 2.09e-04 | 807 | 82 | 10 | M16651 |
| Coexpression | MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS | 2.12e-04 | 37 | 82 | 3 | M18467 | |
| Coexpression | MOHANKUMAR_HOXA1_TARGETS_DN | 2.32e-04 | 176 | 82 | 5 | M9032 | |
| Coexpression | WU_CELL_MIGRATION | 2.77e-04 | 183 | 82 | 5 | M2001 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 2.96e-04 | 289 | 82 | 6 | M41750 | |
| Coexpression | TGFB_UP.V1_UP | 3.22e-04 | 189 | 82 | 5 | M2839 | |
| Coexpression | MENON_FETAL_KIDNEY_2_NEPHRON_PROGENITOR_CELLS | 3.56e-04 | 44 | 82 | 3 | M39252 | |
| Coexpression | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN | 3.59e-04 | 107 | 82 | 4 | M4913 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | 3.61e-04 | 300 | 82 | 6 | M39059 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 3.63e-04 | 194 | 82 | 5 | M39122 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 3.94e-04 | 305 | 82 | 6 | M19875 | |
| Coexpression | GSE3982_BCELL_VS_TH1_DN | 3.98e-04 | 198 | 82 | 5 | M5553 | |
| Coexpression | BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN | 4.07e-04 | 46 | 82 | 3 | M14142 | |
| Coexpression | GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP | 4.08e-04 | 199 | 82 | 5 | M8351 | |
| Coexpression | GSE11924_TH2_VS_TH17_CD4_TCELL_UP | 4.08e-04 | 199 | 82 | 5 | M3164 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 4.13e-04 | 111 | 82 | 4 | M1348 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN | 4.17e-04 | 200 | 82 | 5 | M5216 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN | 4.17e-04 | 200 | 82 | 5 | M5679 | |
| Coexpression | MURAKAMI_UV_RESPONSE_1HR_DN | 4.28e-04 | 10 | 82 | 2 | M9172 | |
| Coexpression | SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER | 4.33e-04 | 47 | 82 | 3 | M11213 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | 4.46e-04 | 888 | 82 | 10 | M39049 | |
| Coexpression | DESCARTES_FETAL_HEART_SATB2_LRRC7_POSITIVE_CELLS | 4.72e-04 | 115 | 82 | 4 | M40201 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_EARLY_MESOTHELIAL_CELL | 4.86e-04 | 584 | 82 | 8 | M45668 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | 5.25e-04 | 591 | 82 | 8 | M2019 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 5.36e-04 | 909 | 82 | 10 | M41018 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | 5.86e-04 | 601 | 82 | 8 | MM866 | |
| Coexpression | AIZARANI_LIVER_C7_EPCAM_POS_BILE_DUCT_CELLS_2 | 6.30e-04 | 219 | 82 | 5 | M39111 | |
| Coexpression | GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_DN | 6.47e-04 | 125 | 82 | 4 | M8930 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 6.52e-04 | 54 | 82 | 3 | M4737 | |
| Coexpression | RODWELL_AGING_KIDNEY_NO_BLOOD_UP | 6.97e-04 | 224 | 82 | 5 | M9893 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 7.07e-04 | 128 | 82 | 4 | MM1000 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 8.04e-04 | 58 | 82 | 3 | M178 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 8.63e-04 | 135 | 82 | 4 | M5825 | |
| Coexpression | KYNG_DNA_DAMAGE_BY_4NQO_OR_UV | 8.88e-04 | 60 | 82 | 3 | M1816 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | NELL2 FN1 NRXN2 SEMA5B LMCD1 WNT3 NTN3 SLIT1 LAMA1 TM4SF4 WNT10A WNT4 DLL1 LRP1B ITGB6 FBN3 PHF21B CRB2 | 2.01e-08 | 986 | 80 | 18 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | ADAMTS19 NELL2 FN1 SEMA5B WNT3 NTN3 SLIT1 LAMA1 TM4SF4 WNT10A WNT4 LRP1B ITGB6 FBN3 PHF21B CRB2 | 7.56e-07 | 994 | 80 | 16 | PCBC_EB_1000 |
| CoexpressionAtlas | Mesoderm Day 30-method_NA_vs_Mesoderm Day 30-method_episomal-Confounder_removed-fold2.0_adjp0.05 | 1.13e-06 | 207 | 80 | 8 | PCBC_ratio_MESO-30_from-ESC_vs_MESO-30_from-episomal_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_NA_vs_Mesoderm Day 30-reprogram_OSK-L-l-p53KD-Confounder_removed-fold2.0_adjp0.05 | 1.13e-06 | 207 | 80 | 8 | PCBC_ratio_MESO-30_from-ESC_vs_MESO-30_from-OSK-L-l-p53KD_cfr-2X-p05 | |
| CoexpressionAtlas | EB blastocyst_vs_EB bone marrow-Confounder_removed-fold2.0_adjp0.05 | 5.98e-06 | 345 | 80 | 9 | PCBC_ratio_EB blastocyst_vs_EB bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | FBLN1 NELL2 CELSR1 NSD2 LAMA1 LAMA4 LRP4 LAMA5 LAMB1 WNT4 DLL1 TMEM52B CDH11 | 6.79e-06 | 783 | 80 | 13 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | SEMA5B SLIT1 LAMA1 TM4SF4 WNT10A WNT4 LRP1B FBN3 PHF21B CRB2 | 1.71e-05 | 497 | 80 | 10 | PCBC_EB_fibroblast_500 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | 1.74e-05 | 498 | 80 | 10 | PCBC_ratio_EB_vs_SC_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | ADAMTS19 NELL2 SEMA5B WNT3 NTN3 SLIT1 LAMA1 TM4SF4 WNT10A WNT4 LRP1B FBN3 PHF21B CRB2 | 1.82e-05 | 992 | 80 | 14 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | FN1 ADAMTSL5 WNT3 NTN3 SLIT1 TM4SF4 WNT10A ESM1 PDGFC LRP1B ITGB3 ITGB6 CDH11 CRB2 | 1.86e-05 | 994 | 80 | 14 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 3.76e-05 | 165 | 80 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#5_top-relative-expression-ranked_100 | 4.78e-05 | 19 | 80 | 3 | gudmap_developingKidney_e14.5 whole kidney - wildtype_100_k5 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 5.13e-05 | 453 | 80 | 9 | GSM777067_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | TNFRSF9 FN1 LMCD1 SLIT1 LAMA1 TM4SF4 WNT10A WNT4 ITGB3 ITGB6 FBN3 PHF21B CRB2 | 7.17e-05 | 981 | 80 | 13 | Arv_EB-LF_1000 |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | FBLN1 FN1 MEGF6 ADAMTSL5 LMCD1 LRP1 LAMA4 ADAM33 CCN2 LIMCH1 ITGB1 ITGB3 CDH11 | 7.86e-05 | 990 | 80 | 13 | JC_fibro_1000 |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 7.99e-05 | 189 | 80 | 6 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500 | 9.07e-05 | 488 | 80 | 9 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 9.82e-05 | 284 | 80 | 7 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_500 | 1.03e-04 | 496 | 80 | 9 | PCBC_EB_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.12e-04 | 391 | 80 | 8 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K5 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 1.27e-04 | 398 | 80 | 8 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 1.28e-04 | 761 | 80 | 11 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | FN1 CPEB4 LAMA1 LAMA5 CCN2 LIMCH1 ADAMTS8 ITGB1 ITGB3 TMEM52B ITGB6 CDH11 | 1.39e-04 | 905 | 80 | 12 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | NELL2 PHPT1 ADAMTS7 LAMA1 MTMR3 NGFR LRP4 LAMA5 LAMB1 ADAM11 DLL1 CDH11 CRB2 | 1.79e-04 | 1075 | 80 | 13 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO bone marrow-Confounder_removed-fold2.0_adjp0.05 | 2.07e-04 | 143 | 80 | 5 | PCBC_ratio_ECTO blastocyst_vs_ECTO bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_100 | 2.08e-04 | 6 | 80 | 2 | gudmap_kidney_P2_CapMes_Crym_k3_100 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_100 | 2.16e-04 | 78 | 80 | 4 | gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_100 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_200 | 2.36e-04 | 32 | 80 | 3 | gudmap_developingKidney_e14.5 whole kidney - wildtype_200_k3 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 2.40e-04 | 437 | 80 | 8 | GSM777046_500 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_500 | 2.43e-04 | 148 | 80 | 5 | gudmap_developingKidney_e12.5_renal vesicle_500_k2 | |
| CoexpressionAtlas | cervix, uterine | 2.50e-04 | 149 | 80 | 5 | cervix, uterine | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 3.14e-04 | 455 | 80 | 8 | GSM777055_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 3.33e-04 | 459 | 80 | 8 | GSM777037_500 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | NELL2 CELSR1 PHPT1 MEGF6 LAMA1 MTMR3 NGFR LAMB1 CCN2 ADAM11 DLL1 PDGFC CDH11 FBN3 CRB2 | 3.36e-04 | 1466 | 80 | 15 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 3.58e-04 | 464 | 80 | 8 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_200 | 3.68e-04 | 162 | 80 | 5 | gudmap_developingKidney_e15.5_S-shaped body_200 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 3.69e-04 | 466 | 80 | 8 | GSM777050_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 4.12e-04 | 166 | 80 | 5 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.35e-04 | 168 | 80 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#4_top-relative-expression-ranked_500 | 4.60e-04 | 40 | 80 | 3 | gudmap_kidney_adult_Mesangium_Meis_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500 | 4.87e-04 | 486 | 80 | 8 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500 | 5.00e-04 | 371 | 80 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 5.24e-04 | 175 | 80 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#4_top-relative-expression-ranked_200 | 5.32e-04 | 42 | 80 | 3 | gudmap_developingKidney_e15.5_S-shaped body_200_k4 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.52e-04 | 177 | 80 | 5 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_k3_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 5.57e-04 | 496 | 80 | 8 | PCBC_EB_blastocyst_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_1000 | CELSR1 NCAPG SLIT1 LAMA1 LAMB1 CCN2 LIMCH1 WNT4 DLL1 TMEM52B | 5.63e-04 | 761 | 80 | 10 | gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 5.64e-04 | 497 | 80 | 8 | PCBC_ECTO_fibroblast_500 | |
| CoexpressionAtlas | Mesoderm Day 15-reprogram_NA_vs_Mesoderm Day 15-reprogram_OSK-L-l-p53KD-Confounder_removed-fold2.0_adjp0.05 | 5.81e-04 | 179 | 80 | 5 | PCBC_ratio_MESO-15_from-ESC_vs_MESO-15_from-OSK-L-l-p53KD_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 15-method_NA_vs_Mesoderm Day 15-method_episomal-Confounder_removed-fold2.0_adjp0.05 | 5.81e-04 | 179 | 80 | 5 | PCBC_ratio_MESO-15_from-ESC_vs_MESO-15_from-episomal_cfr-2X-p05 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_100 | 6.19e-04 | 10 | 80 | 2 | gudmap_kidney_P1_CapMes_Crym_k2_100 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_500 | 6.22e-04 | 385 | 80 | 7 | gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 6.26e-04 | 182 | 80 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 6.62e-04 | 280 | 80 | 6 | PCBC_ratio_ECTO blastocyst_vs_ECTO amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500 | 6.69e-04 | 105 | 80 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#5_top-relative-expression-ranked_500 | 6.69e-04 | 105 | 80 | 4 | gudmap_developingKidney_e14.5 whole kidney - wildtype_500_k5 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 6.74e-04 | 281 | 80 | 6 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#4 | 6.74e-04 | 281 | 80 | 6 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K4 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 6.74e-04 | 281 | 80 | 6 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K4 | 6.92e-04 | 392 | 80 | 7 | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#3 | 7.00e-04 | 283 | 80 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K3 | |
| CoexpressionAtlas | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1 | 8.02e-04 | 402 | 80 | 7 | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_100 | 9.03e-04 | 12 | 80 | 2 | gudmap_kidney_P0_CapMes_Crym_k1_100 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_500 | 9.12e-04 | 411 | 80 | 7 | gudmap_developingKidney_e12.5_renal vesicle_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#5_top-relative-expression-ranked_200 | 9.41e-04 | 51 | 80 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_200_k5 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_1000 | ARHGAP5 NELL2 NCAPG CPEB4 LAMA1 ESM1 TMEM52B ZBTB1 ITGB6 CDH11 | 9.44e-04 | 814 | 80 | 10 | gudmap_kidney_e15.5_Podocyte_MafB_1000 |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_200 | 9.96e-04 | 52 | 80 | 3 | gudmap_developingKidney_e12.5_renal vesicle_200_k2 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | 1.04e-03 | 975 | 80 | 11 | PCBC_ctl_CardiacMyocyte_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | SNED1 ABLIM1 NELL2 NRXN2 SEMA5B LMCD1 LAMA5 ADAM33 DLL1 PDGFC PHF21B | 1.05e-03 | 976 | 80 | 11 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.10e-03 | 309 | 80 | 6 | ratio_EB_vs_SC_2500_K5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.11e-03 | 54 | 80 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | SNED1 ABLIM1 NELL2 CELSR1 SEMA5B LMCD1 LAMA5 ADAM33 DLL1 PDGFC ITGB6 | 1.12e-03 | 984 | 80 | 11 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.14e-03 | 208 | 80 | 5 | gudmap_developingLowerUrinaryTract_adult_bladder_1000_k3 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | ADAMTS19 NELL2 SLIT1 LAMA1 WNT4 ZNF782 DLL1 TNXB FBN3 PHF21B CRB2 | 1.19e-03 | 991 | 80 | 11 | PCBC_ECTO_fibroblast_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | ABLIM1 CELSR1 NRXN2 SEMA5B ADAMTS7 LAMA1 LAMA5 CCN2 DLL1 ZBTB1 PHF21B | 1.19e-03 | 991 | 80 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.21e-03 | 123 | 80 | 4 | Arv_EB-LF_1000_K5 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.23e-03 | 433 | 80 | 7 | Arv_EB-LF_1000_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.28e-03 | 125 | 80 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500_k-means-cluster#4 | 1.44e-03 | 59 | 80 | 3 | Arv_EB-LF_500_K4 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.44e-03 | 445 | 80 | 7 | GSM777043_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.48e-03 | 130 | 80 | 4 | gudmap_developingKidney_e15.5_1000_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.48e-03 | 130 | 80 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | ABLIM1 CELSR1 NCAPG SEMA5B NSD2 SLIT1 LAMA1 LRP4 LAMA5 CCN2 ADAM11 DLL1 PHF21B | 1.50e-03 | 1347 | 80 | 13 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | EB amniotic fluid MSC_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.63e-03 | 727 | 80 | 9 | PCBC_ratio_EB amniotic fluid MSC_vs_EB blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 1.66e-03 | 456 | 80 | 7 | GSM777032_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | 1.66e-03 | 456 | 80 | 7 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 1.66e-03 | 62 | 80 | 3 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.69e-03 | 336 | 80 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.71e-03 | 228 | 80 | 5 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.79e-03 | 137 | 80 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K4 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 1.90e-03 | 65 | 80 | 3 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | FBLN1 FN1 LMCD1 SLIT1 LRP1 LAMA4 LAMB1 CCN2 LIMCH1 ADAMTS8 TNXB CDH11 | 2.53e-15 | 199 | 82 | 12 | b4a737575be9f8c65771832dd8cd25328d5dae0d |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FBLN1 FN1 LMCD1 LRP1 LAMA4 LAMB1 CCN2 LIMCH1 ADAMTS8 TNXB CDH11 | 8.17e-14 | 195 | 82 | 11 | df409f94f4e83be89f7a608058ee07ce3ce3a149 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FBLN1 FN1 LMCD1 LRP1 LAMA4 LAMB1 CCN2 LIMCH1 ADAMTS8 TNXB CDH11 | 8.17e-14 | 195 | 82 | 11 | 4243190ad291d56694e2155954dbaa879c9d3844 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | FBLN1 FN1 PDGFD LAMA1 LRP1 LAMA4 LAMB1 LIMCH1 ADAMTS8 TNXB CDH11 | 1.02e-13 | 199 | 82 | 11 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | FBLN1 FN1 LMCD1 LRP1 LAMA4 LAMB1 CCN2 LIMCH1 ADAMTS8 TNXB CDH11 | 1.02e-13 | 199 | 82 | 11 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | FBLN1 FN1 LMCD1 LRP1 LAMA4 LAMB1 CCN2 LIMCH1 ADAMTS8 TNXB CDH11 | 1.02e-13 | 199 | 82 | 11 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | FBLN1 FN1 PDGFD LAMA1 LRP1 LAMA4 LAMB1 LIMCH1 ADAMTS8 TNXB CDH11 | 1.08e-13 | 200 | 82 | 11 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | Basal|World / shred by cell class for mouse tongue | CELSR1 MEGF6 SLIT1 LAMA3 WNT10A LAMA5 LAMB1 SIVA1 DLL1 ITGB1 | 1.61e-12 | 183 | 82 | 10 | c6729a207526ff4aa48176207b9353176f631fea |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.99e-12 | 187 | 82 | 10 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.73e-12 | 193 | 82 | 10 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.03e-12 | 195 | 82 | 10 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-12 | 196 | 82 | 10 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-12 | 196 | 82 | 10 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-12 | 196 | 82 | 10 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.35e-12 | 197 | 82 | 10 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-12 | 197 | 82 | 10 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.35e-12 | 197 | 82 | 10 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | PND14-Mesenchymal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-12 | 197 | 82 | 10 | 9a14bc2e7d6081e2ab0e2e5555fc8804f13d3dbe | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-12 | 197 | 82 | 10 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.52e-12 | 198 | 82 | 10 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.52e-12 | 198 | 82 | 10 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.70e-12 | 199 | 82 | 10 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.70e-12 | 199 | 82 | 10 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.70e-12 | 199 | 82 | 10 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.70e-12 | 199 | 82 | 10 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 3.89e-12 | 200 | 82 | 10 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.89e-12 | 200 | 82 | 10 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | FBLN1 PDGFD LAMA1 LRP1 LAMA4 LAMB1 LIMCH1 ADAMTS8 TNXB CDH11 | 3.89e-12 | 200 | 82 | 10 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 3.89e-12 | 200 | 82 | 10 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.89e-12 | 200 | 82 | 10 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.89e-12 | 200 | 82 | 10 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | SNED1 FBLN1 NRXN2 LRP1 LAMA4 LAMB1 ADAM33 ADAMTS8 TNXB CDH11 | 3.89e-12 | 200 | 82 | 10 | 1c10597edd532bf172ca09870a937d35e2585081 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.89e-12 | 200 | 82 | 10 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.21e-11 | 177 | 82 | 9 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.21e-11 | 177 | 82 | 9 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | facs-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.57e-11 | 189 | 82 | 9 | bdf8db938aa0863c4fed6fa99dcffd63c8c20c31 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.57e-11 | 189 | 82 | 9 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | droplet-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.93e-11 | 190 | 82 | 9 | 0b7200897b2c389632c9b1ee37e272b811555dbc | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.31e-11 | 191 | 82 | 9 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.31e-11 | 191 | 82 | 9 | 80484d39f34703a33b9bac09826b7a526e883cab | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.31e-11 | 191 | 82 | 9 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.31e-11 | 191 | 82 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.12e-11 | 193 | 82 | 9 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.12e-11 | 193 | 82 | 9 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 9.12e-11 | 193 | 82 | 9 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.12e-11 | 193 | 82 | 9 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.55e-11 | 194 | 82 | 9 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.55e-11 | 194 | 82 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.55e-11 | 194 | 82 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-10 | 195 | 82 | 9 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.10e-10 | 197 | 82 | 9 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 1.10e-10 | 197 | 82 | 9 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 1.15e-10 | 198 | 82 | 9 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-10 | 198 | 82 | 9 | d83707b69fb64721ac3cff90ba58cdd999d6b386 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.15e-10 | 198 | 82 | 9 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-10 | 198 | 82 | 9 | 75d104eead681f6bf47c4dd24913cc768c9a1717 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.20e-10 | 199 | 82 | 9 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.20e-10 | 199 | 82 | 9 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.20e-10 | 199 | 82 | 9 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.20e-10 | 199 | 82 | 9 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.20e-10 | 199 | 82 | 9 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-10 | 199 | 82 | 9 | 675f7c56b03a7918e2d9ca99440df6f27ad8e838 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.20e-10 | 199 | 82 | 9 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-10 | 199 | 82 | 9 | 97d74985018816754d11a55b9fb689690ecb1374 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-10 | 199 | 82 | 9 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.25e-10 | 200 | 82 | 9 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | 343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-10 | 200 | 82 | 9 | 376c1a77031e090be96948b47c78ac0d393f5775 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.25e-10 | 200 | 82 | 9 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.25e-10 | 200 | 82 | 9 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-10 | 200 | 82 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-10 | 200 | 82 | 9 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.25e-10 | 200 | 82 | 9 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-10 | 200 | 82 | 9 | 750ff51c9de08aecec230f4a402e0bf5a789f24c | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.25e-10 | 200 | 82 | 9 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.25e-10 | 200 | 82 | 9 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-10 | 200 | 82 | 9 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-10 | 200 | 82 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-10 | 200 | 82 | 9 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-10 | 200 | 82 | 9 | fda92cb28de99a9c4fe83b7db8145a4beafb0826 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-10 | 200 | 82 | 9 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.25e-10 | 200 | 82 | 9 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.25e-10 | 200 | 82 | 9 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 7.44e-10 | 164 | 82 | 8 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-09 | 176 | 82 | 8 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-09 | 176 | 82 | 8 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-09 | 182 | 82 | 8 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-09 | 182 | 82 | 8 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-09 | 183 | 82 | 8 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.93e-09 | 185 | 82 | 8 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-09 | 186 | 82 | 8 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.10e-09 | 187 | 82 | 8 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-09 | 188 | 82 | 8 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.19e-09 | 188 | 82 | 8 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.28e-09 | 189 | 82 | 8 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-09 | 189 | 82 | 8 | 40cbd679dc0548bf5207e1b033c0597886ad6fe1 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-09 | 189 | 82 | 8 | 324c81285c51f4f8bb1aef428b18fe2c549c2c11 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-09 | 189 | 82 | 8 | e76dc36a01d8ad7590b3acc4c46abfcb76857448 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.38e-09 | 190 | 82 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.48e-09 | 191 | 82 | 8 | 44a9a6768084dafc641ad455b65862bfd4cc0cb9 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-09 | 191 | 82 | 8 | a261f0738d974784bbdd60f23092bfbcca464459 | |
| Computational | Adhesion molecules. | 5.20e-07 | 141 | 55 | 8 | MODULE_122 | |
| Computational | DRG (dorsal root ganglia) genes. | 2.09e-05 | 384 | 55 | 10 | MODULE_2 | |
| Computational | Genes in the cancer module 275. | 6.77e-05 | 16 | 55 | 3 | MODULE_275 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.10e-04 | 49 | 55 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.19e-04 | 50 | 55 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2 | |
| Computational | ECM and collagens. | 1.38e-04 | 225 | 55 | 7 | MODULE_47 | |
| Computational | Neighborhood of CDH11 | 2.69e-04 | 25 | 55 | 3 | GNF2_CDH11 | |
| Computational | Neighborhood of PTX3 | 8.03e-04 | 36 | 55 | 3 | GNF2_PTX3 | |
| Drug | Rgd Peptide | FBLN1 FN1 ADAMTSL5 LAMA3 LAMA4 LAMA5 LAMB1 TNR ITGB1 ITGB3 TNXB ITGB6 ITGB7 FBN3 | 1.57e-13 | 239 | 82 | 14 | CID000104802 |
| Drug | Sikvav | 1.99e-12 | 24 | 82 | 7 | CID005487517 | |
| Drug | Ikvav | 6.98e-11 | 38 | 82 | 7 | CID000131343 | |
| Drug | ALT-711 | 9.41e-11 | 21 | 82 | 6 | CID000216304 | |
| Drug | Gdrgdsp | 2.07e-10 | 109 | 82 | 9 | CID000115346 | |
| Drug | AC1L1G72 | 2.43e-10 | 11 | 82 | 5 | CID000003553 | |
| Drug | BM165 | 2.43e-10 | 11 | 82 | 5 | CID003352881 | |
| Drug | Grgds | 6.33e-10 | 83 | 82 | 8 | CID000123811 | |
| Drug | trypanothione disulfide | 1.94e-09 | 140 | 82 | 9 | CID000115098 | |
| Drug | chondroitin sulfate | FBLN1 FN1 ADAMTSL5 SEMA5B ADAMTS7 LAMA3 LAMA4 LAMA5 LAMB1 LTF TNR ITGB1 TNXB | 2.74e-09 | 413 | 82 | 13 | CID000024766 |
| Drug | Rgds Peptide | 4.52e-09 | 106 | 82 | 8 | CID000107775 | |
| Drug | YIGSR | 1.42e-08 | 79 | 82 | 7 | CID000123977 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 2.02e-08 | 83 | 82 | 7 | CID011968896 | |
| Drug | kalinin | 4.56e-08 | 55 | 82 | 6 | CID000032518 | |
| Drug | AC1L1B58 | 5.94e-08 | 29 | 82 | 5 | CID000001288 | |
| Drug | LMWH | FBLN1 FN1 ADAMTSL5 LAMA1 LRP1 LAMA3 LAMA4 LAMA5 LAMB1 CCN2 ADAMTS8 LTF TNR TNXB | 9.73e-08 | 663 | 82 | 14 | CID000000772 |
| Drug | DB04780 | 1.82e-07 | 170 | 82 | 8 | CID005459389 | |
| Drug | Calcort | 2.45e-07 | 38 | 82 | 5 | CID000026709 | |
| Drug | dysprosium | 2.76e-07 | 74 | 82 | 6 | CID000023912 | |
| Drug | Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; HL60; HT_HG-U133A | 5.84e-07 | 198 | 82 | 8 | 3033_UP | |
| Drug | Reidispongiolide C | 7.35e-07 | 279 | 82 | 9 | CID005289285 | |
| Drug | I-Q-S | 1.53e-06 | 156 | 82 | 7 | CID000003540 | |
| Drug | CC270 | 2.30e-06 | 59 | 82 | 5 | CID006918852 | |
| Drug | AC1L9INI | 2.30e-06 | 59 | 82 | 5 | CID000445839 | |
| Drug | LG 5 | 2.50e-06 | 60 | 82 | 5 | CID011840957 | |
| Drug | hyaluronan | 4.86e-06 | 263 | 82 | 8 | CID000024759 | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 6.93e-06 | 196 | 82 | 7 | 2270_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 7.17e-06 | 197 | 82 | 7 | 5633_UP | |
| Drug | A0395 | 7.59e-06 | 75 | 82 | 5 | CID009906466 | |
| Drug | AC1L1KMJ | 8.09e-06 | 476 | 82 | 10 | CID000030956 | |
| Drug | 2-amino-5-methylpyridine | 8.64e-06 | 77 | 82 | 5 | CID000015348 | |
| Drug | NSC 714187 | 1.40e-05 | 85 | 82 | 5 | CID005288693 | |
| Drug | dermatan sulfate | 1.47e-05 | 220 | 82 | 7 | CID000032756 | |
| Drug | 1,2-dimethylhydrazine | 1.48e-05 | 86 | 82 | 5 | CID000001322 | |
| Drug | Toxins, Biological | TNFRSF9 FN1 SEMA5B WNT3 LAMA3 WNT10A LAMA5 WNT4 ITGB3 ITGB6 ITGB7 | 1.62e-05 | 632 | 82 | 11 | ctd:D014118 |
| Drug | poly-N-acetyllactosamine | 1.66e-05 | 88 | 82 | 5 | CID000119547 | |
| Drug | quinaprilat | 1.73e-05 | 43 | 82 | 4 | CID000107994 | |
| Drug | H-9 dihydrochloride | 1.85e-05 | 90 | 82 | 5 | CID000003544 | |
| Drug | oxypertine | 2.93e-05 | 49 | 82 | 4 | CID000004640 | |
| Drug | XLF-III-43 | 3.84e-05 | 3 | 82 | 2 | ctd:C548351 | |
| Drug | 2,4-diaminopyrimidine | 4.31e-05 | 54 | 82 | 4 | CID000067431 | |
| Drug | bromochloroacetic acid | 4.67e-05 | 109 | 82 | 5 | ctd:C099813 | |
| Drug | AC1L1C2F | 4.88e-05 | 110 | 82 | 5 | CID000001711 | |
| Drug | Leu-asp-val | 4.91e-05 | 20 | 82 | 3 | CID000130816 | |
| Drug | N-acetylhexosamine | 5.03e-05 | 472 | 82 | 9 | CID000000899 | |
| Drug | B-Ms | 5.78e-05 | 114 | 82 | 5 | CID000445091 | |
| Drug | colchine | 7.18e-05 | 383 | 82 | 8 | CID000002833 | |
| Drug | Monobenzone [103-16-2]; Up 200; 20uM; HL60; HT_HG-U133A | 7.45e-05 | 195 | 82 | 6 | 3054_UP | |
| Drug | Delcorine; Up 200; 8.4uM; MCF7; HT_HG-U133A | 7.45e-05 | 195 | 82 | 6 | 3613_UP | |
| Drug | 3-ethylpyridine | 7.65e-05 | 4 | 82 | 2 | CID000010823 | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A | 7.67e-05 | 196 | 82 | 6 | 3817_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A | 7.67e-05 | 196 | 82 | 6 | 3732_UP | |
| Drug | rotenone; Down 200; 1uM; PC3; HT_HG-U133A | 7.89e-05 | 197 | 82 | 6 | 5948_DN | |
| Drug | Gemfibrozil [25812-30-0]; Up 200; 16uM; PC3; HT_HG-U133A | 7.89e-05 | 197 | 82 | 6 | 5069_UP | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 7.89e-05 | 197 | 82 | 6 | 3939_UP | |
| Drug | Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 7.89e-05 | 197 | 82 | 6 | 3168_UP | |
| Drug | Cotinine (-) [486-56-6]; Up 200; 22.6uM; MCF7; HT_HG-U133A | 7.89e-05 | 197 | 82 | 6 | 5611_UP | |
| Drug | Carbimazole [22232-54-8]; Up 200; 21.4uM; MCF7; HT_HG-U133A | 8.11e-05 | 198 | 82 | 6 | 5399_UP | |
| Drug | Niacin [59-67-6]; Up 200; 32.4uM; MCF7; HT_HG-U133A | 8.11e-05 | 198 | 82 | 6 | 3381_UP | |
| Drug | LY 294002; Up 200; 0.1uM; PC3; HT_HG-U133A | 8.57e-05 | 200 | 82 | 6 | 4440_UP | |
| Drug | MRK 003 | TMEFF1 ABLIM1 CELSR1 TNFRSF9 FN1 ADAMTS7 LMCD1 LAMA4 CCN2 DLL1 MEGF11 | 8.63e-05 | 760 | 82 | 11 | ctd:C523799 |
| Drug | indole-3-acetyl-l-valine | 8.95e-05 | 65 | 82 | 4 | CID000446641 | |
| Drug | N-methylformamide | 9.50e-05 | 66 | 82 | 4 | CID000031254 | |
| Drug | 2,3-pentanedione | 1.04e-04 | 129 | 82 | 5 | ctd:C013186 | |
| Drug | G 3012 | 1.16e-04 | 132 | 82 | 5 | CID000120739 | |
| Drug | manganese | FN1 LAMA1 LAMA3 LAMA4 LAMA5 LAMB1 LTF ITGB1 ITGB3 ITGB6 ITGB7 | 1.23e-04 | 791 | 82 | 11 | CID000023930 |
| Drug | 2-(2,6-dioxopiperidin-3-yl)phthalimidine | 1.27e-04 | 5 | 82 | 2 | ctd:C001079 | |
| Drug | Smoke | USP6 ABLIM1 CELSR1 TNFRSF9 FN1 LAMA1 NGFR LAMA4 LAMA5 CCN2 LTF WNT4 | 1.28e-04 | 937 | 82 | 12 | ctd:D012906 |
| Drug | iodide | 1.29e-04 | 534 | 82 | 9 | CID000024841 | |
| Drug | monatepil | 1.54e-04 | 29 | 82 | 3 | CID000060810 | |
| Drug | Aluminum Oxide | 1.56e-04 | 75 | 82 | 4 | ctd:D000537 | |
| Drug | belinostat | 1.59e-04 | 678 | 82 | 10 | ctd:C487081 | |
| Drug | Chlorpyrifos | TMEFF1 NCAPG FN1 SLIT1 NGFR LAMA5 PRKN CCN2 WNT4 MUC2 TNR ARL5A | 1.61e-04 | 960 | 82 | 12 | ctd:D004390 |
| Drug | genistein | NELL2 FN1 ADAMTS7 LAMA1 LAMA3 LAMA4 LAMA5 LAMB1 ADAM11 ITGB1 ITGB3 ITGB6 ITGB7 | 1.70e-04 | 1117 | 82 | 13 | CID005280961 |
| Drug | 2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide | 1.88e-04 | 31 | 82 | 3 | ctd:C577942 | |
| Drug | cyclofenil | 1.88e-04 | 31 | 82 | 3 | CID000002898 | |
| Drug | fenugreek seed meal | 1.90e-04 | 6 | 82 | 2 | ctd:C056164 | |
| Drug | AC1O5SNJ | 1.90e-04 | 6 | 82 | 2 | CID006439900 | |
| Drug | 2-GG | 1.90e-04 | 6 | 82 | 2 | CID016058668 | |
| Drug | 1,2,5,6-dibenzanthracene | ABLIM1 FBLN1 FN1 MEGF6 PDGFD LAMA1 NGFR LAMA4 ESM1 CCN2 PDGFC | 2.01e-04 | 837 | 82 | 11 | ctd:C026486 |
| Drug | zoledronic acid | FBLN1 TNFRSF9 NCAPG PHPT1 SEMA5B LAMA1 TM4SF4 LAMA3 LAMA4 LAMA5 LAMB1 LIMCH1 PDGFC TMEM52B MEGF11 | 2.20e-04 | 1472 | 82 | 15 | ctd:C088658 |
| Drug | Paclitaxel | 2.58e-04 | 720 | 82 | 10 | ctd:D017239 | |
| Drug | Te-6 | 2.71e-04 | 35 | 82 | 3 | CID000198470 | |
| Drug | Betamethasone-d5 | FN1 LAMA1 LRP1 NGFR LAMA3 LAMA4 LAMA5 LAMB1 CCN2 ITGB1 ITGB3 ITGB6 ITGB7 FBN3 | 2.85e-04 | 1340 | 82 | 14 | CID000003003 |
| Drug | L-lysyl-L-lysyl-L-lysine | 3.01e-04 | 162 | 82 | 5 | CID000072363 | |
| Drug | sphingosine 1-phosphate | 3.20e-04 | 37 | 82 | 3 | ctd:C060506 | |
| Drug | tranylcypromine | 3.29e-04 | 91 | 82 | 4 | CID000005530 | |
| Drug | gentiopicroside | 3.54e-04 | 8 | 82 | 2 | CID000088708 | |
| Drug | GRGDTP | 3.54e-04 | 8 | 82 | 2 | CID004644096 | |
| Drug | 1-methylcyclopentanecarboxylic acid | 3.88e-04 | 95 | 82 | 4 | CID000138436 | |
| Drug | isocycloheximide | TNFRSF9 FN1 LAMA1 LRP1 LAMA3 LAMA4 LRP4 LAMA5 LAMB1 LTF LRP1B | 3.91e-04 | 905 | 82 | 11 | CID000002900 |
| Disease | cortical thickness | NELL2 CELSR1 ADAMTS7 WNT3 CPEB4 LAMA1 MTMR3 LRP1 LRP4 ADAMTS8 PDGFC CDH11 MIEF2 CRB2 | 1.61e-06 | 1113 | 80 | 14 | EFO_0004840 |
| Disease | Astrocytosis | 1.27e-05 | 17 | 80 | 3 | C3887640 | |
| Disease | Gliosis | 1.27e-05 | 17 | 80 | 3 | C0017639 | |
| Disease | Hyalinosis, Segmental Glomerular | 5.99e-05 | 28 | 80 | 3 | C0086432 | |
| Disease | cortical surface area measurement | ADAMTS19 CELSR1 ZAN MEGF6 ADAMTS7 WNT3 PDGFD CPEB4 WNT4 PDGFC TNXB CDH11 FBN3 | 6.33e-05 | 1345 | 80 | 13 | EFO_0010736 |
| Disease | Autistic Disorder | 7.86e-05 | 261 | 80 | 6 | C0004352 | |
| Disease | FEV/FEC ratio | TRIM33 FBLN1 NELL2 MEGF6 LMCD1 CPEB4 MTMR3 LRP1 ADAM33 WNT4 TNXB CRB2 | 1.13e-04 | 1228 | 80 | 12 | EFO_0004713 |
| Disease | Focal glomerulosclerosis | 1.28e-04 | 36 | 80 | 3 | C0017668 | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 1.51e-04 | 7 | 80 | 2 | C0399367 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.14e-04 | 447 | 80 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | Early Pregnancy Loss | 2.25e-04 | 109 | 80 | 4 | C3830362 | |
| Disease | Spontaneous abortion | 2.25e-04 | 109 | 80 | 4 | C0000786 | |
| Disease | Miscarriage | 2.25e-04 | 109 | 80 | 4 | C4552766 | |
| Disease | Abortion, Tubal | 2.25e-04 | 109 | 80 | 4 | C0000822 | |
| Disease | membranoproliferative glomerulonephritis (biomarker_via_orthology) | 3.22e-04 | 10 | 80 | 2 | DOID:2920 (biomarker_via_orthology) | |
| Disease | Lymphoma, Lymphocytic, Intermediate | 3.93e-04 | 11 | 80 | 2 | C0751958 | |
| Disease | Aortic Valve Insufficiency | 3.93e-04 | 11 | 80 | 2 | C0003504 | |
| Disease | serum IgG glycosylation measurement | 5.50e-04 | 523 | 80 | 7 | EFO_0005193 | |
| Disease | cancer (implicated_via_orthology) | 8.22e-04 | 268 | 80 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 8.50e-04 | 16 | 80 | 2 | C0334634 | |
| Disease | glomerulonephritis (implicated_via_orthology) | 9.61e-04 | 17 | 80 | 2 | DOID:2921 (implicated_via_orthology) | |
| Disease | Endometrioma | 9.78e-04 | 161 | 80 | 4 | C0269102 | |
| Disease | Endometriosis | 9.78e-04 | 161 | 80 | 4 | C0014175 | |
| Disease | Lewy body dementia (is_marker_for) | 1.20e-03 | 19 | 80 | 2 | DOID:12217 (is_marker_for) | |
| Disease | glomerulonephritis (is_marker_for) | 1.20e-03 | 19 | 80 | 2 | DOID:2921 (is_marker_for) | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 1.34e-03 | 20 | 80 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | urate measurement, bone density | 1.46e-03 | 619 | 80 | 7 | EFO_0003923, EFO_0004531 | |
| Disease | Alveolitis, Fibrosing | 1.51e-03 | 83 | 80 | 3 | C4721507 | |
| Disease | Pulmonary Fibrosis | 1.62e-03 | 85 | 80 | 3 | C0034069 | |
| Disease | Autism Spectrum Disorders | 1.62e-03 | 85 | 80 | 3 | C1510586 | |
| Disease | waist-hip ratio | 1.74e-03 | 1226 | 80 | 10 | EFO_0004343 | |
| Disease | descending aortic diameter | 1.78e-03 | 88 | 80 | 3 | EFO_0021788 | |
| Disease | vital capacity | 1.84e-03 | 1236 | 80 | 10 | EFO_0004312 | |
| Disease | response to peginterferon alfa-2a | 2.09e-03 | 25 | 80 | 2 | EFO_0010103 | |
| Disease | primary biliary cholangitis (is_marker_for) | 2.09e-03 | 25 | 80 | 2 | DOID:12236 (is_marker_for) | |
| Disease | indole-3-propionate measurement | 2.44e-03 | 27 | 80 | 2 | EFO_0010501 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 2.44e-03 | 27 | 80 | 2 | DOID:10584 (implicated_via_orthology) | |
| Disease | amino acid measurement | 2.44e-03 | 678 | 80 | 7 | EFO_0005134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ACCALTGEGLCQGLE | 156 | Q9Y689 | |
| CAGCGRDIKNGQALL | 226 | O14639 | |
| LDKCGVCGGKGNSCR | 676 | Q9UP79 | |
| GSVQECSRAGGNCCK | 461 | O75078 | |
| CAGRDALCGKLQCQG | 566 | Q9BZ11 | |
| RCANGVCKNGGTCVN | 1406 | Q9NYQ6 | |
| NGGTCRGASCLCQKG | 126 | Q75N90 | |
| GCLCCSVKDNGLRAI | 106 | Q5RIA9 | |
| RDLCINGICKNVGCD | 661 | Q9UKP4 | |
| CANGRCQKVGCDGLL | 756 | Q8TE59 | |
| LICGGNGVCKCRVCE | 566 | P05556 | |
| ASNGQICNGRGICEC | 601 | P05556 | |
| LVKRCGGNCACCLHN | 276 | Q9NRA1 | |
| GKDCGRVCQCQNGAS | 746 | A6BM72 | |
| SCKLTCENGGRCILN | 4216 | Q9NZR2 | |
| CVVNGGDVRCSCKAG | 1746 | Q16787 | |
| KDGCRNGGACIAANV | 526 | Q99435 | |
| AANCSCLEGLAGQRC | 1156 | Q5IJ48 | |
| KCRVNNGGCSSLCLA | 806 | Q07954 | |
| KRCRNKCGCLGGCRF | 1121 | Q2LD37 | |
| GCLCCSVKDNGLRAI | 106 | Q8IUF1 | |
| CLLVQRCGGNCGCGT | 296 | Q9GZP0 | |
| RHKGLLCGGNGDCDC | 546 | P18564 | |
| KNCVCLEGGSGIICQ | 4836 | Q02817 | |
| LDCLGNEKTVCRCGA | 1181 | O96028 | |
| LKQCASAPCRNGGVC | 691 | Q9P2S2 | |
| SCLGLGRLLGDCQAC | 601 | Q7Z7M0 | |
| CIVILASGCCGKQQG | 301 | A6NHS7 | |
| GCRPCDCDLGGALNN | 506 | P07942 | |
| EGCVLRGGRTQCLCK | 1926 | O15230 | |
| GGQSLCEKLLCACDQ | 381 | Q02509 | |
| LENCGCADLGNCAIK | 1766 | A2RRP1 | |
| VCVAGRCLSAGCDGL | 166 | Q6ZMM2 | |
| QSARGVACLGCKGTC | 21 | Q9NZU5 | |
| GLCSGHGRCKCNRCQ | 611 | P26010 | |
| VGGRCKCNGHASRCL | 251 | O00634 | |
| LNDRCRGGGPCKQQC | 176 | P23142 | |
| CDSGRCIARKLECNG | 146 | P13671 | |
| CIARKLECNGENDCG | 151 | P13671 | |
| KGLLGNRNCCRGGAG | 36 | O00548 | |
| LQCICTGNGRGEWKC | 256 | P02751 | |
| LDGCGCCRVCAKQLG | 51 | P29279 | |
| GCLCCSVKDNGLRAI | 106 | Q5JTY5 | |
| GCLCCSVKDNGLRAI | 106 | Q4V339 | |
| KVCGCDVNGALLSCN | 591 | P55287 | |
| SNGLLCSGRGKCECG | 596 | P05106 | |
| NCQSGICDRGTGKCL | 116 | Q9NQ30 | |
| LCDECQGARCGGKFA | 666 | Q17RY0 | |
| GCRVILCNENCLEGA | 46 | Q0D2K5 | |
| HIQCFRCGICKGQLG | 1036 | Q9UPQ0 | |
| AAAVANRAKGGGCEC | 321 | Q13615 | |
| DARIAKNCAVCNCGG | 231 | Q16363 | |
| DCRNGGTCLLGLDGC | 526 | O75095 | |
| CAVCRGCSALGQLGR | 361 | Q96C03 | |
| GSILCDQIGGQCNCK | 651 | O75445 | |
| AVCQNGGDLLCCEKC | 891 | Q9UPN9 | |
| NGLGCGFAFCRECKE | 356 | O60260 | |
| PNLCRLCAGTGENKC | 186 | P02788 | |
| LCALCVGDEQGRNKC | 531 | P08582 | |
| LQGGKICRCFCNCDD | 601 | Q96RN1 | |
| GQCVCRLGASGLRCD | 1526 | P25391 | |
| LCLRCCLLEGAGGAE | 326 | P31391 | |
| DKGNCGVGKSCLCNR | 26 | Q13017 | |
| KQGCDCECLGGGRIS | 66 | Q9NRX4 | |
| DCECRNGGRCLGANT | 471 | Q8TER0 | |
| NGGRCLGANTTLCQC | 476 | Q8TER0 | |
| RNLAVLCLGCCGLQN | 601 | Q9BPX3 | |
| LCLGCCGLQNQDFAR | 606 | Q9BPX3 | |
| CGECGNCFGRQSTLK | 356 | Q15697 | |
| AACKRGANLQPCGTC | 356 | Q96EK2 | |
| GECCKACNLGEGVAQ | 41 | P08138 | |
| GRGRCENGVCVCNAG | 441 | P22105 | |
| SGKGRCANGTCLCEE | 271 | Q92752 | |
| DCGQRQCLNACSGRG | 291 | Q92752 | |
| QCLNACSGRGQCEEG | 296 | Q92752 | |
| AGGQRTCDICRQCKG | 56 | Q07011 | |
| RCCCLSRQQNGEDGG | 66 | Q4KMG9 | |
| GCQLQVRCGQLLACG | 1146 | Q6ZS81 | |
| GIDGCDLLCCGRGHN | 306 | P56703 | |
| SLQNCCLTGAGCGVL | 91 | P13489 | |
| RRACENGNSCLGCGV | 746 | Q9P283 | |
| NICACGKCGQILVKG | 446 | Q9Y2K1 | |
| KAIDGCELLCCGRGF | 301 | P56705 | |
| CKCDIAGSACQGLSL | 136 | Q6ZMW2 | |
| GVCKEDGDGLKCACQ | 86 | Q8IYR6 | |
| SNACALGKLKACGCD | 146 | Q9GZT5 | |
| CTCSNGIVDCRGKGL | 286 | O75093 | |
| SCPGQGCCQGLRLKR | 1491 | O75093 | |
| FLGLKNNDCCGCCGN | 66 | P48230 | |
| VDGKAVCGQCERALC | 121 | O15304 | |
| EGLCGQCASLGCLLR | 256 | P35125 | |
| AKIGAFCCGLSLCNQ | 176 | Q9NX78 | |
| KCVCTGGAIQCGDFR | 2291 | Q9Y493 | |
| NKCGSRNGGCSHLCL | 1311 | O75096 |